<!DOCTYPE html>

<html>

<head>

<meta charset="utf-8" />
<meta name="generator" content="pandoc" />
<meta http-equiv="X-UA-Compatible" content="IE=EDGE" />




<title>ImmPort Data Analysis</title>

<script src="site_libs/jquery-1.11.3/jquery.min.js"></script>
<meta name="viewport" content="width=device-width, initial-scale=1" />
<link href="site_libs/bootstrap-3.3.5/css/cosmo.min.css" rel="stylesheet" />
<script src="site_libs/bootstrap-3.3.5/js/bootstrap.min.js"></script>
<script src="site_libs/bootstrap-3.3.5/shim/html5shiv.min.js"></script>
<script src="site_libs/bootstrap-3.3.5/shim/respond.min.js"></script>
<script src="site_libs/navigation-1.1/tabsets.js"></script>
<link href="site_libs/highlightjs-9.12.0/default.css" rel="stylesheet" />
<script src="site_libs/highlightjs-9.12.0/highlight.js"></script>
<script src="site_libs/kePrint-0.0.1/kePrint.js"></script>

<style type="text/css">code{white-space: pre;}</style>
<style type="text/css">
  pre:not([class]) {
    background-color: white;
  }
</style>
<script type="text/javascript">
if (window.hljs) {
  hljs.configure({languages: []});
  hljs.initHighlightingOnLoad();
  if (document.readyState && document.readyState === "complete") {
    window.setTimeout(function() { hljs.initHighlighting(); }, 0);
  }
}
</script>



<style type="text/css">
h1 {
  font-size: 34px;
}
h1.title {
  font-size: 38px;
}
h2 {
  font-size: 30px;
}
h3 {
  font-size: 24px;
}
h4 {
  font-size: 18px;
}
h5 {
  font-size: 16px;
}
h6 {
  font-size: 12px;
}
.table th:not([align]) {
  text-align: left;
}
</style>




<style type = "text/css">
.main-container {
  max-width: 940px;
  margin-left: auto;
  margin-right: auto;
}
code {
  color: inherit;
  background-color: rgba(0, 0, 0, 0.04);
}
img {
  max-width:100%;
}
.tabbed-pane {
  padding-top: 12px;
}
.html-widget {
  margin-bottom: 20px;
}
button.code-folding-btn:focus {
  outline: none;
}
summary {
  display: list-item;
}
</style>


<style type="text/css">
/* padding for bootstrap navbar */
body {
  padding-top: 51px;
  padding-bottom: 40px;
}
/* offset scroll position for anchor links (for fixed navbar)  */
.section h1 {
  padding-top: 56px;
  margin-top: -56px;
}
.section h2 {
  padding-top: 56px;
  margin-top: -56px;
}
.section h3 {
  padding-top: 56px;
  margin-top: -56px;
}
.section h4 {
  padding-top: 56px;
  margin-top: -56px;
}
.section h5 {
  padding-top: 56px;
  margin-top: -56px;
}
.section h6 {
  padding-top: 56px;
  margin-top: -56px;
}
.dropdown-submenu {
  position: relative;
}
.dropdown-submenu>.dropdown-menu {
  top: 0;
  left: 100%;
  margin-top: -6px;
  margin-left: -1px;
  border-radius: 0 6px 6px 6px;
}
.dropdown-submenu:hover>.dropdown-menu {
  display: block;
}
.dropdown-submenu>a:after {
  display: block;
  content: " ";
  float: right;
  width: 0;
  height: 0;
  border-color: transparent;
  border-style: solid;
  border-width: 5px 0 5px 5px;
  border-left-color: #cccccc;
  margin-top: 5px;
  margin-right: -10px;
}
.dropdown-submenu:hover>a:after {
  border-left-color: #ffffff;
}
.dropdown-submenu.pull-left {
  float: none;
}
.dropdown-submenu.pull-left>.dropdown-menu {
  left: -100%;
  margin-left: 10px;
  border-radius: 6px 0 6px 6px;
}
</style>

<script>
// manage active state of menu based on current page
$(document).ready(function () {
  // active menu anchor
  href = window.location.pathname
  href = href.substr(href.lastIndexOf('/') + 1)
  if (href === "")
    href = "index.html";
  var menuAnchor = $('a[href="' + href + '"]');

  // mark it active
  menuAnchor.parent().addClass('active');

  // if it's got a parent navbar menu mark it active as well
  menuAnchor.closest('li.dropdown').addClass('active');
});
</script>

<!-- tabsets -->

<style type="text/css">
.tabset-dropdown > .nav-tabs {
  display: inline-table;
  max-height: 500px;
  min-height: 44px;
  overflow-y: auto;
  background: white;
  border: 1px solid #ddd;
  border-radius: 4px;
}

.tabset-dropdown > .nav-tabs > li.active:before {
  content: "";
  font-family: 'Glyphicons Halflings';
  display: inline-block;
  padding: 10px;
  border-right: 1px solid #ddd;
}

.tabset-dropdown > .nav-tabs.nav-tabs-open > li.active:before {
  content: "&#xe258;";
  border: none;
}

.tabset-dropdown > .nav-tabs.nav-tabs-open:before {
  content: "";
  font-family: 'Glyphicons Halflings';
  display: inline-block;
  padding: 10px;
  border-right: 1px solid #ddd;
}

.tabset-dropdown > .nav-tabs > li.active {
  display: block;
}

.tabset-dropdown > .nav-tabs > li > a,
.tabset-dropdown > .nav-tabs > li > a:focus,
.tabset-dropdown > .nav-tabs > li > a:hover {
  border: none;
  display: inline-block;
  border-radius: 4px;
  background-color: transparent;
}

.tabset-dropdown > .nav-tabs.nav-tabs-open > li {
  display: block;
  float: none;
}

.tabset-dropdown > .nav-tabs > li {
  display: none;
}
</style>

<!-- code folding -->




</head>

<body>


<div class="container-fluid main-container">




<div class="navbar navbar-default  navbar-fixed-top" role="navigation">
  <div class="container">
    <div class="navbar-header">
      <button type="button" class="navbar-toggle collapsed" data-toggle="collapse" data-target="#navbar">
        <span class="icon-bar"></span>
        <span class="icon-bar"></span>
        <span class="icon-bar"></span>
      </button>
      <a class="navbar-brand" href="index.html">ImmPort Data Analysis</a>
    </div>
    <div id="navbar" class="navbar-collapse collapse">
      <ul class="nav navbar-nav">
        <li>
  <a href="index.html">Home</a>
</li>
<li>
  <a href="MemoryCD4_CD8.html">MemoryCD4_CD8</a>
</li>
<li>
  <a href="MemoryBcells.html">MemoryBcells</a>
</li>
<li>
  <a href="Tregs.html">T regs</a>
</li>
<li>
  <a href="SDY67.html">SDY67</a>
</li>
      </ul>
      <ul class="nav navbar-nav navbar-right">
        
      </ul>
    </div><!--/.nav-collapse -->
  </div><!--/.container -->
</div><!--/.navbar -->

<div class="fluid-row" id="header">



<h1 class="title toc-ignore">ImmPort Data Analysis</h1>

</div>


<div id="introduction" class="section level2">
<h2>Introduction</h2>
<p><a href="https://www.immport.org/shared/home">ImmPort</a> is a publicly available database that hosts Immunology research data.</p>
<p>This re-analysis aims to:</p>
<ul>
<li><p>identify cell populations from Influenza vaccine response studies on ImmPort database using DAFi autogating approach</p></li>
<li><p>mapping the meta-data using SQL queries to individual panels</p></li>
<li><p>identifying correlations between cell population percentages and ab-titer data</p></li>
<li><p>identifying reproducible longitudinal patterns for the cell populations across studies</p></li>
<li><p>modeling data using lmer to identify significant cohort-level differences for the longitudinal data</p></li>
</ul>
</div>
<div id="dafi-auto-gating-approach" class="section level2">
<h2>DAFi Auto-gating approach</h2>
<p><a href="https://onlinelibrary.wiley.com/doi/full/10.1002/cyto.a.23371">DAFi: A Directed recursive data filtering and clustering approach</a> is a data-driven computational approach that utilizes the existing data clustering methods for effectively and reliably accomplishing the task of auto-gating for identifying user-defined and novel cell populations from multi-dimensional FCM data in an interpretable way.</p>
</div>
<div id="influenza-vaccine-response-studies-on-immport-database" class="section level2">
<h2>Influenza vaccine response studies on ImmPort database</h2>
<div id="study-summary" class="section level4">
<h4>Study Summary</h4>
<p>There are 55 Influenza vaccine studies with flow cytometry data on ImmPort database. The studies are summarized in the following table (scroll to the right for more details). Studies highlighted in gray could not be used for the analysis.</p>
<p>Each study had multiple panels (based on the markers in the FCS files). However, the meta data did not have any information regarding the panels. The first step was to know the panel information and separate the FCS files based on the panel markers. The markers were extracted for each FCS file in each study, and the FCS files were grouped based on the markers studied.</p>
<div style="border: 1px solid #ddd; padding: 0px; overflow-y: scroll; height:400px; overflow-x: scroll; width:100%; ">
<table class="table table-striped table-bordered" style="width: auto !important; margin-left: auto; margin-right: auto;">
<thead>
<tr>
<th style="text-align:left;position: sticky; top:0; background-color: #FFFFFF;">
ImmPort.ID
</th>
<th style="text-align:left;position: sticky; top:0; background-color: #FFFFFF;">
PI
</th>
<th style="text-align:left;position: sticky; top:0; background-color: #FFFFFF;">
Institution
</th>
<th style="text-align:left;position: sticky; top:0; background-color: #FFFFFF;">
Study.Title
</th>
<th style="text-align:left;position: sticky; top:0; background-color: #FFFFFF;">
Study.Description
</th>
<th style="text-align:left;position: sticky; top:0; background-color: #FFFFFF;">
Hypothesis/Objective
</th>
<th style="text-align:left;position: sticky; top:0; background-color: #FFFFFF;">
Species
</th>
<th style="text-align:left;position: sticky; top:0; background-color: #FFFFFF;">
Inclusion.Criteria/Study.Arms
</th>
<th style="text-align:left;position: sticky; top:0; background-color: #FFFFFF;">
Number.of.Subjects
</th>
<th style="text-align:left;position: sticky; top:0; background-color: #FFFFFF;">
Assay.Types
</th>
<th style="text-align:left;position: sticky; top:0; background-color: #FFFFFF;">
FCM.data
</th>
<th style="text-align:left;position: sticky; top:0; background-color: #FFFFFF;">
Ab.titer
</th>
<th style="text-align:left;position: sticky; top:0; background-color: #FFFFFF;">
Gene.Expression.data
</th>
<th style="text-align:left;position: sticky; top:0; background-color: #FFFFFF;">
Companion.studies
</th>
<th style="text-align:left;position: sticky; top:0; background-color: #FFFFFF;">
Demographics
</th>
<th style="text-align:left;position: sticky; top:0; background-color: #FFFFFF;">
Arm
</th>
<th style="text-align:left;position: sticky; top:0; background-color: #FFFFFF;">
Visits
</th>
<th style="text-align:left;position: sticky; top:0; background-color: #FFFFFF;">
Cell.Definition
</th>
<th style="text-align:left;position: sticky; top:0; background-color: #FFFFFF;">
Notes
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
SDY113
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
Harry Greenberg
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
Stanford University
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
Plasmablast response to inactivated and live attenuated influenza vaccines (TIV3/TIV3 ID/LAIV) in 2011
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
To study the plasmablast response to influenza vaccines
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
plasmablast resposne to LAIV vs TIV vs ID TIV
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
Homo sapiens
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
18-30 years old; ITV(intramuscularly with Fluzone)/ID TIV (intradermally with Fluzone)/LAIV (FluMist)
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
70
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
ELISPOT for ASC; ELISA; HAI; FCM; CyTOF; whole blood DNA microarray; Luminex xMAP for serum cytokine quantification;
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
Yes
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
Yes (Hai_result)
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
No
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
No
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
Ethnicity, Gender, Race, Age (subject)
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
LAIV, TIV, ID TIV (arm 2 cohort and arm 2 subject )
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
0, 7, 28 Days
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
Yes (IK_cell_population, IK_cell_population_marker)
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
NA
</td>
</tr>
<tr>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
SDY305
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
Harry Greenberg
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
Stanford University
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
Plasmablast response to inactivated and live attenuated influenza vaccines (TIV3/TIV3 ID) in 2012
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
To study the plasmablast response to 2012 seasonal inactivated influenza vaccine
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
plasmablast response after TIV or ID TIV immunization in recipients of the same type of vaccines in the prior year.
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
Homo sapiens
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
18-32 year old; TIV and ID TIV
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
25
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
ELISPOT for ASC; ELISA; HAI; FCM; CyTOF; whole blood DNA microarray; Luminex xMAP for serum cytokine quantification;
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
Yes
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
Yes
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
.CEL files
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
No
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
Ethnicity, Gender, Race, Age (Subject)
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
TIV, ID TIV (arm 2 cohort and arm 2 subject)
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
0, 7, 28 Days
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
Yes (IK_cell_population, IK_cell_population_marker)
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
NA
</td>
</tr>
<tr>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
SDY202
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
Harry Greenberg
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
Stanford University
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
Heterovariant cross-reactive B-cell responses induced by the 2009 pandemic influenza virus A subtype H1N1 vaccine
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
To study the plasmablast response to monovalent inactivated 2009 pandemic pH1N1 vaccine
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
To measure plasmablast resposne to monovalent inactivated influenza pH1N1 vaccines
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
Homo sapiens
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
18-32 year old adults; 60-69 year old adults; &gt;69 year old adults; immunized intramuscularly inactivated pH1N1 vaccine
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
79
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
ELISPOT for ASC; ELISA; HAI; FCM (phenotyping; H1N1_phospho); Luminex xMAP for serum cytokine quantification;
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
Yes
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
Yes (Hai_result)
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
No
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
No
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
Ethnicity, Gender, Race, Age (subject)
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
Control, pH1N1 vaccine
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
0, 7, 14, 28 Days
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
Yes (IK_cell_population, IK_cell_population_marker)
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
NA
</td>
</tr>
<tr>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
SDY38
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
David Topham
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
NYICE
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
CD8+ T cell immunity to 2009 pandemic and seasonal H1N1 influenza viruses
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
Flow cytometry was used to measure the expression of IL2, IFN gamma and TNF alpha in CD8+ peripheral blood mononuclear cells isolated from healthy naive donors following stimulation with whole virus.
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
Healthy adults without prior exposure to pH1N1 will have pre-existing pH1N1-responsive CD8+ T cells as a result of previous exposure to sH1N1
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
Homo sapiens
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
Healthy adults with ages 18-50
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
12
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
FCM
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
Yes
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
No
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
No
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
No
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
Ethnicity, Gender, Race, Age (subject)
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
NA
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
1 Day
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
Yes (IK_cell_population, IK_cell_population_marker)
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
NA
</td>
</tr>
<tr>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
SDY241
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
David Topham and Hulin Wu
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
University of Rochester
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
Simulation and Prediction of the Adaptive Immune Response and Quantification of Early and Adaptive Immune Response Kinetics to Influenza A Virus Infection
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
Modeling approaches were combined with experimental data to investigate innate and adaptive immune responses to IAV infection. Mathematical models developed describe the dynamic interactions between influenza virus, target cells, cytotoxic lymphocytes, and virus-specific IgG and IgM. In additon, a two-compartment model developed quantifies the effects of viral replication and adaptive immunity.
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
Develop a two-compartment mathematical model to assess the individual contributions of antigen presentation and activation of naive T and B cells by antigen-presenting cells (APC), CD4 T-cell help, CD8 T-cell-mediated cytotoxicity, B cells and antibody to control influenza A virus (IAV) infection and to explore the influence of anatomical location.
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
Mouse
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
C57/BL6
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
495
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
FCM; ELISA; ELISPOT
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
Yes
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
No
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
No
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
No
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
Ethnicity, Gender, Race, Age (subject)
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
Control, x31 Treated, WSN-OVA II Treated, HeLA vBMW1 Treated
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
NA
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
Yes (IK_cell_population, IK_cell_population_marker)
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
NA
</td>
</tr>
<tr>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
SDY224
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
Hulin Wu and Martin Zand
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
University of Rochester
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
Immune Responses to Seasonal TIV 2010-2011 Influenza Vaccination in Humans (see companion study SDY396,SDY564)
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
To use system biology approaches to compare differences in immune responses to vaccine
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
Develop detailed, multi-level, multi-scale high dimensional mathematical models of the immune response to seasonal influenza vaccination
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
Homo sapiens
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
Healthy adults ages 18 to 69 years
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
14
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
FCM (B, T); ELISA; ELISPOT; RNA-seq (B, PBMC); HAI
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
Yes
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
Yes (Hai_result)
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
Yes (reads)
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
SDY 396, SDY 564
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
Ethnicity, Gender, Race, Age (subject)
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
TIV vaccine
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
Pre, post vaccination
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
Yes (IK_cell_population, IK_cell_population_marker)
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
NA
</td>
</tr>
<tr>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
SDY396
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
Hulin Wu and Martin Zand
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
University of Rochester
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
Immune Responses to Seasonal LAIV 2011-2012 Influenza Vaccination in Humans (see companion study SDY224,SDY564)
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
To use system biology approaches to compare differences in immune responses to vaccine
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
Develop detailed, multi-level, multi-scale high dimensional mathematical models of the immune response to seasonal influenza vaccination
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
Homo sapiens
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
Healthy adults ages 18 to 69 years
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
18
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
FCM (B, T); ELISA; ELISPOT; RNA-seq (B, PBMC); HAI
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
Yes
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
Yes (Hai_result)
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
No
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
SDY 224, SDY 564
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
Ethnicity, Gender, Race, Age (subject)
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
LAIV vaccine
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
NA
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
Yes (IK_cell_population, IK_cell_population_marker)
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
NA
</td>
</tr>
<tr>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
SDY564
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
Hulin Wu and Martin Zand
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
University of Rochester
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
Immune Responses to Seasonal TIV 2012-2013 Influenza Vaccination in Humans (see companion study SDY396,SDY224)
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
To use system biology approaches to compare differences in immune responses to vaccine
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
Develop detailed, multi-level, multi-scale high dimensional mathematical models of the immune response to seasonal influenza vaccination
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
Homo sapiens
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
Healthy adults ages 18 to 69 years
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
10
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
FCM (B, T); ELISA; ELISPOT; HAI
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
Yes
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
Yes (Hai_result)
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
No
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
SDY 396, SDY 224
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
Ethnicity, Gender, Race, Age (subject)
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
TIV vaccine
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
NA
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
Yes (IK_cell_population, IK_cell_population_marker)
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
NA
</td>
</tr>
<tr>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
SDY583
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
Martin Zand, Mark Sangster
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
University of Rochester Center for Biodefense Immune Modeling
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
Immune Responses to Seasonal Influenza Vaccination in Mouse model
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
Seasonal influenza vaccine study with Murine subject
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
Design and conduct in vivo murine experiments to build, identify and experimentally validate the proposed immune response models by generating high frequency sampling and high dimensional datasets from mice with TIV vaccinations.
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
Mouse
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
female C57BL/6Ntac
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
66
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
ELISPOT; FCM
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
Yes
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
No
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
No
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
No
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
NA
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
NA
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
NA
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
Yes (IK_cell_population, IK_cell_population_marker)
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
NA
</td>
</tr>
<tr>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
SDY585
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
Martin Zand
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
University of Rochester Center for Biodefense Immune Modeling
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
2013 Murine Vaccine with Adjuvant Study
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
Study of Influenza vaccine coupled with adjuvant in Murine model
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
Design and conduct in vivo murine experiments with X31(H3N2) infection primed and purified inactivated A/Port Chalmers/1/73 (H3N2) whole virus with MF59-like adjuvant boosted mice to build, identify and experimentally validate the proposed immune response models by generating high frequency sampling and high dimensional datasets.
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
Mouse
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
female C57BL/6
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
36
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
ELISPOT; FCM
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
Yes
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
No
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
No
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
No
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
NA
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
NA
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
NA
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
Yes (IK_cell_population, IK_cell_population_marker)
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
NA
</td>
</tr>
<tr>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
SDY56
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
Bali Pulendran
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
Emory University
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
Systems Biology of trivalent Influenza vaccine (TIV) in young and elderly
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
Single center, open label study in which adult healthy volunteers with no contraindications to immunization will be vaccinated with TIV. Blood samples will be collected on Days D0 (at enrollment) and D1, D3, D7, D14, D30, D180 post vaccination to study innate and/or adaptive immunity markers. Even though influenza vaccination is considered safe, volunteers will be asked to report any local or systemic AEs from Day 0 (vaccination) to Day 7 in memory aids. Reactogenicity events will also be evaluated by injection site examination on visits at D0, D1, D3 and D7. Volunteers will be also asked to report local and systemic AEs developing the day of a blood draw.
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
To identify innate signatures that correlate with the magnitude, quality and persistence of B cell responses after vaccination with TIV in the young versus the elderly.
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
Homo sapiens
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
25-40 years old; &gt;65 years old
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
92
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
HAI; FCM; DNA micrroarray; Luminex xMAP; microRNA profiling
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
Yes
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
Yes
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
.CEL files
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
SDY 61, SDY 270, SDY 119
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
Ethnicity, Gender, Race, Age (subject)
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
25-40 years old; &gt;65 years old
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
multiple
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
Yes (IK_cell_population, IK_cell_population_marker)
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
NA
</td>
</tr>
<tr>
<td style="text-align:left;color: black !important;background-color: gray !important;border-left:1px solid;border-right:1px solid;">
SDY61
</td>
<td style="text-align:left;color: black !important;background-color: gray !important;border-left:1px solid;border-right:1px solid;">
Bali Pulendran
</td>
<td style="text-align:left;color: black !important;background-color: gray !important;border-left:1px solid;border-right:1px solid;">
Emory University
</td>
<td style="text-align:left;color: black !important;background-color: gray !important;border-left:1px solid;border-right:1px solid;">
Systems Biology of 2007 Influenza Vaccination in Humans (See companion studies SDY269 2008 / SDY270 2009 / SDY271 Role for CaMKIV in the Regulation of Antibody Responses to Influenza Vaccine)
</td>
<td style="text-align:left;color: black !important;background-color: gray !important;border-left:1px solid;border-right:1px solid;">
Using a systems biology approach to study innate and adaptive responses to influenza vaccination in humans during the 2007-2008 influenza season
</td>
<td style="text-align:left;color: black !important;background-color: gray !important;border-left:1px solid;border-right:1px solid;">
Detailed characterization of the innate and adaptive responses to vaccination with TIV and LAIV to identify putative early signature with or predicted later immunogenicity in order to obtain new insight into the mechanisms underlying immunogenicity.
</td>
<td style="text-align:left;color: black !important;background-color: gray !important;border-left:1px solid;border-right:1px solid;">
Homo sapiens
</td>
<td style="text-align:left;color: black !important;background-color: gray !important;border-left:1px solid;border-right:1px solid;">
LAIV vs TIV
</td>
<td style="text-align:left;color: black !important;background-color: gray !important;border-left:1px solid;border-right:1px solid;">
12
</td>
<td style="text-align:left;color: black !important;background-color: gray !important;border-left:1px solid;border-right:1px solid;">
HAI; FCM; DNA micrroarray; qRT-PCR of RNA from PBMC
</td>
<td style="text-align:left;color: black !important;background-color: gray !important;border-left:1px solid;border-right:1px solid;">
4 files
</td>
<td style="text-align:left;color: black !important;background-color: gray !important;border-left:1px solid;border-right:1px solid;">
Yes (Hai_result)
</td>
<td style="text-align:left;color: black !important;background-color: gray !important;border-left:1px solid;border-right:1px solid;">
Yes
</td>
<td style="text-align:left;color: black !important;background-color: gray !important;border-left:1px solid;border-right:1px solid;">
SDY 269, SDY 270, SDY 271
</td>
<td style="text-align:left;color: black !important;background-color: gray !important;border-left:1px solid;border-right:1px solid;">
Ethnicity, Gender, Race, Age (subject)
</td>
<td style="text-align:left;color: black !important;background-color: gray !important;border-left:1px solid;border-right:1px solid;">
LAIV, TIV
</td>
<td style="text-align:left;color: black !important;background-color: gray !important;border-left:1px solid;border-right:1px solid;">
0, 28 Days
</td>
<td style="text-align:left;color: black !important;background-color: gray !important;border-left:1px solid;border-right:1px solid;">
Yes (IK_cell_population, IK_cell_population_marker)
</td>
<td style="text-align:left;color: black !important;background-color: gray !important;border-left:1px solid;border-right:1px solid;">
4 FCS files only No Gene Expression data
</td>
</tr>
<tr>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
SDY269
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
Bali Pulendran
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
Emory University
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
Systems Biology of 2008 Influenza Vaccination in Humans (See companion studies SDY61 2007 / SDY270 2009 / SDY271 Role for CaMKIV in the Regulation of Antibody Responses to Influenza Vaccine)
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
Using a systems biology approach to study innate and adaptive responses to influenza vaccination in humans during the 2008-2009 influenza season.
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
Detailed characterization of the innate and adaptive responses to vaccination with TIV and LAIV to identify putative early signature with or predicted later immunogenicity in order to obtain new insight into the mechanisms underlying immunogenicity.
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
Homo sapiens
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
healthy adult
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
63
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
ELISPOT; Luminex xMAP; HAI; FCM; DNA microarray; q-PCR of RNA from PBMC
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
Yes
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
Yes (Hai_result)
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
Yes
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
SDY 61, SDY 270, SDY 271
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
Ethnicity, Gender, Race, Age (subject)
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
LAIV, TIV
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
0, 28 Days
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
Yes (IK_cell_population, IK_cell_population_marker)
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
NA
</td>
</tr>
<tr>
<td style="text-align:left;color: black !important;background-color: gray !important;border-left:1px solid;border-right:1px solid;">
SDY270
</td>
<td style="text-align:left;color: black !important;background-color: gray !important;border-left:1px solid;border-right:1px solid;">
Bali Pulendran
</td>
<td style="text-align:left;color: black !important;background-color: gray !important;border-left:1px solid;border-right:1px solid;">
Emory University
</td>
<td style="text-align:left;color: black !important;background-color: gray !important;border-left:1px solid;border-right:1px solid;">
Systems Biology of 2009 Influenza Vaccination in Humans (See companion studies SDY61 2007 / SDY269 2008 / SDY271 Role for CaMKIV in the Regulation of Antibody Responses to Influenza Vaccine)
</td>
<td style="text-align:left;color: black !important;background-color: gray !important;border-left:1px solid;border-right:1px solid;">
Using a systems biology approach to study innate and adaptive responses to influenza vaccination in humans during the 2009-2010 influenza season.
</td>
<td style="text-align:left;color: black !important;background-color: gray !important;border-left:1px solid;border-right:1px solid;">
Detailed characterization of the innate and adaptive responses to vaccination with TIV and LAIV to identify putative early signature with or predicted later immunogenicity in order to obtain new insight into the mechanisms underlying immunogenicity.
</td>
<td style="text-align:left;color: black !important;background-color: gray !important;border-left:1px solid;border-right:1px solid;">
Homo sapiens
</td>
<td style="text-align:left;color: black !important;background-color: gray !important;border-left:1px solid;border-right:1px solid;">
healthy adult
</td>
<td style="text-align:left;color: black !important;background-color: gray !important;border-left:1px solid;border-right:1px solid;">
30
</td>
<td style="text-align:left;color: black !important;background-color: gray !important;border-left:1px solid;border-right:1px solid;">
HAI; microarray; q-PCR of RNA from PBMC
</td>
<td style="text-align:left;color: black !important;background-color: gray !important;border-left:1px solid;border-right:1px solid;">
No
</td>
<td style="text-align:left;color: black !important;background-color: gray !important;border-left:1px solid;border-right:1px solid;">
No
</td>
<td style="text-align:left;color: black !important;background-color: gray !important;border-left:1px solid;border-right:1px solid;">
No
</td>
<td style="text-align:left;color: black !important;background-color: gray !important;border-left:1px solid;border-right:1px solid;">
SDY 61, SDY 269, SDY 271
</td>
<td style="text-align:left;color: black !important;background-color: gray !important;border-left:1px solid;border-right:1px solid;">
Ethnicity, Gender, Race, Age (subject)
</td>
<td style="text-align:left;color: black !important;background-color: gray !important;border-left:1px solid;border-right:1px solid;">
LAIV, TIV
</td>
<td style="text-align:left;color: black !important;background-color: gray !important;border-left:1px solid;border-right:1px solid;">
0, 7 Days
</td>
<td style="text-align:left;color: black !important;background-color: gray !important;border-left:1px solid;border-right:1px solid;">
Yes (IK_cell_population, IK_cell_population_marker)
</td>
<td style="text-align:left;color: black !important;background-color: gray !important;border-left:1px solid;border-right:1px solid;">
NA
</td>
</tr>
<tr>
<td style="text-align:left;color: black !important;background-color: gray !important;border-left:1px solid;border-right:1px solid;">
SDY271
</td>
<td style="text-align:left;color: black !important;background-color: gray !important;border-left:1px solid;border-right:1px solid;">
Bali Pulendran
</td>
<td style="text-align:left;color: black !important;background-color: gray !important;border-left:1px solid;border-right:1px solid;">
Emory University
</td>
<td style="text-align:left;color: black !important;background-color: gray !important;border-left:1px solid;border-right:1px solid;">
Role for CaMKIV in the Regulation of Antibody Responses to Influenza Vaccine (See companion studies SDY61 2007 / SDY269 2008 / SDY270 2009)
</td>
<td style="text-align:left;color: black !important;background-color: gray !important;border-left:1px solid;border-right:1px solid;">
To demonstrate that the gene signatures identified in this study can generate new hypotheses, we selected one gene in the predictive signature, calcium/calmodulin-dependent protein kinase IV (CaMKIV), for functional validation experiments. The CamkIV gene is involved in several processes of the immune system, such as T cell development,inflammatory response and hematopoietic stem cell maintenance. However, nothing is known about the possible role of CaMKIV in B cell responses. The fold-change in expression of the CaMKIV gene on day 3 post-TIV vaccination is negatively correlated with the antibody response on day 28 post-vaccination in two independent trials. Additionally, fold-change expression of CaMKIV is negatively correlated with the expansion of IgG-secreting plasmablasts at day 7, suggesting a possible role for this gene in the regulation of antibody responses to influenza vaccination.
</td>
<td style="text-align:left;color: black !important;background-color: gray !important;border-left:1px solid;border-right:1px solid;">
Confirm gene expression and vaccine studies results for CaMKIV (Pubmed 21743478)
</td>
<td style="text-align:left;color: black !important;background-color: gray !important;border-left:1px solid;border-right:1px solid;">
Homo sapiens and Mouse
</td>
<td style="text-align:left;color: black !important;background-color: gray !important;border-left:1px solid;border-right:1px solid;">
CamKIV mouse; WT mouse; Control mouse; CamKIV healthy adults
</td>
<td style="text-align:left;color: black !important;background-color: gray !important;border-left:1px solid;border-right:1px solid;">
36
</td>
<td style="text-align:left;color: black !important;background-color: gray !important;border-left:1px solid;border-right:1px solid;">
ELISA; Immunoblot; qRT-PCR of RNA
</td>
<td style="text-align:left;color: black !important;background-color: gray !important;border-left:1px solid;border-right:1px solid;">
No
</td>
<td style="text-align:left;color: black !important;background-color: gray !important;border-left:1px solid;border-right:1px solid;">
No
</td>
<td style="text-align:left;color: black !important;background-color: gray !important;border-left:1px solid;border-right:1px solid;">
No
</td>
<td style="text-align:left;color: black !important;background-color: gray !important;border-left:1px solid;border-right:1px solid;">
SDY 61, SDY 269, SDY 270
</td>
<td style="text-align:left;color: black !important;background-color: gray !important;border-left:1px solid;border-right:1px solid;">
Ethnicity, Gender, Race, Age (subject)
</td>
<td style="text-align:left;color: black !important;background-color: gray !important;border-left:1px solid;border-right:1px solid;">
TIV
</td>
<td style="text-align:left;color: black !important;background-color: gray !important;border-left:1px solid;border-right:1px solid;">
7, 14, 28 Days
</td>
<td style="text-align:left;color: black !important;background-color: gray !important;border-left:1px solid;border-right:1px solid;">
Yes (IK_cell_population, IK_cell_population_marker)
</td>
<td style="text-align:left;color: black !important;background-color: gray !important;border-left:1px solid;border-right:1px solid;">
NA
</td>
</tr>
<tr>
<td style="text-align:left;color: black !important;background-color: gray !important;border-left:1px solid;border-right:1px solid;">
SDY63
</td>
<td style="text-align:left;color: black !important;background-color: gray !important;border-left:1px solid;border-right:1px solid;">
David Hafler
</td>
<td style="text-align:left;color: black !important;background-color: gray !important;border-left:1px solid;border-right:1px solid;">
Yale
</td>
<td style="text-align:left;color: black !important;background-color: gray !important;border-left:1px solid;border-right:1px solid;">
Immunologic and genomic signatures of influenza vaccine response - 2010 (see companion studies SDY400, SDY404, SDY520)
</td>
<td style="text-align:left;color: black !important;background-color: gray !important;border-left:1px solid;border-right:1px solid;">
Project 1: Immunologic and genomic signatures of influenza vaccine response - year1 2010
</td>
<td style="text-align:left;color: black !important;background-color: gray !important;border-left:1px solid;border-right:1px solid;">
Identification of immunologic, gene expression, and genetic loci signatures of vaccine response, and effects of aging and functional status on these signatures.
</td>
<td style="text-align:left;color: black !important;background-color: gray !important;border-left:1px solid;border-right:1px solid;">
Homo sapiens
</td>
<td style="text-align:left;color: black !important;background-color: gray !important;border-left:1px solid;border-right:1px solid;">
Young adults 21-30 years old; older adults &gt;=65 years old
</td>
<td style="text-align:left;color: black !important;background-color: gray !important;border-left:1px solid;border-right:1px solid;">
49
</td>
<td style="text-align:left;color: black !important;background-color: gray !important;border-left:1px solid;border-right:1px solid;">
HAI; DNA microarray (PBMC, T, B)
</td>
<td style="text-align:left;color: black !important;background-color: gray !important;border-left:1px solid;border-right:1px solid;">
No
</td>
<td style="text-align:left;color: black !important;background-color: gray !important;border-left:1px solid;border-right:1px solid;">
Yes (Hai_result)
</td>
<td style="text-align:left;color: black !important;background-color: gray !important;border-left:1px solid;border-right:1px solid;">
No
</td>
<td style="text-align:left;color: black !important;background-color: gray !important;border-left:1px solid;border-right:1px solid;">
SDY 400, SDY 404, SDY 520
</td>
<td style="text-align:left;color: black !important;background-color: gray !important;border-left:1px solid;border-right:1px solid;">
Ethnicity, Gender, Race, Age (subject)
</td>
<td style="text-align:left;color: black !important;background-color: gray !important;border-left:1px solid;border-right:1px solid;">
Age
</td>
<td style="text-align:left;color: black !important;background-color: gray !important;border-left:1px solid;border-right:1px solid;">
NA
</td>
<td style="text-align:left;color: black !important;background-color: gray !important;border-left:1px solid;border-right:1px solid;">
Yes (IK_cell_population, IK_cell_population_marker)
</td>
<td style="text-align:left;color: black !important;background-color: gray !important;border-left:1px solid;border-right:1px solid;">
NA
</td>
</tr>
<tr>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
SDY404
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
David Hafler
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
Yale
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
Project 1: Immunologic and genomic signatures of influenza vaccine response - year2 2011
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
Identification of immunologic, gene expression, and genetic loci signatures of vaccine response, and effects of aging and functional status on these signatures.
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
Homo sapiens
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
Young adults 21-30 years old; older adults &gt;=65 years old
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
72
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
DNA microarray (PBMC, B, T); HAI; FCM
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
Yes
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
Yes (Hai_result)
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
No
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
SDY 63, SDY 400, SDY 520
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
Ethnicity, Gender, Race, Age (subject)
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
Age
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
NA
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
Yes (IK_cell_population, IK_cell_population_marker)
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
NA
</td>
</tr>
<tr>
<td style="text-align:left;color: black !important;background-color: gray !important;border-left:1px solid;border-right:1px solid;">
SDY400
</td>
<td style="text-align:left;color: black !important;background-color: gray !important;border-left:1px solid;border-right:1px solid;">
David Hafler
</td>
<td style="text-align:left;color: black !important;background-color: gray !important;border-left:1px solid;border-right:1px solid;">
Yale
</td>
<td style="text-align:left;color: black !important;background-color: gray !important;border-left:1px solid;border-right:1px solid;">
Immunologic and genomic signatures of influenza vaccine response - 2012 (see companion studies SDY63, SDY404, SDY520)
</td>
<td style="text-align:left;color: black !important;background-color: gray !important;border-left:1px solid;border-right:1px solid;">
Project 1: Immunologic and genomic signatures of influenza vaccine response - year3 2012
</td>
<td style="text-align:left;color: black !important;background-color: gray !important;border-left:1px solid;border-right:1px solid;">
Identification of immunologic, gene expression, and genetic loci signatures of vaccine response, and effects of aging and functional status on these signatures.
</td>
<td style="text-align:left;color: black !important;background-color: gray !important;border-left:1px solid;border-right:1px solid;">
Homo sapiens
</td>
<td style="text-align:left;color: black !important;background-color: gray !important;border-left:1px solid;border-right:1px solid;">
Young adults 21-30 years old; older adults &gt;=65 years old
</td>
<td style="text-align:left;color: black !important;background-color: gray !important;border-left:1px solid;border-right:1px solid;">
98
</td>
<td style="text-align:left;color: black !important;background-color: gray !important;border-left:1px solid;border-right:1px solid;">
HAI; DNA microarray
</td>
<td style="text-align:left;color: black !important;background-color: gray !important;border-left:1px solid;border-right:1px solid;">
No
</td>
<td style="text-align:left;color: black !important;background-color: gray !important;border-left:1px solid;border-right:1px solid;">
Yes (Hai_result)
</td>
<td style="text-align:left;color: black !important;background-color: gray !important;border-left:1px solid;border-right:1px solid;">
No
</td>
<td style="text-align:left;color: black !important;background-color: gray !important;border-left:1px solid;border-right:1px solid;">
SDY 63, SDY 404, SDY 520
</td>
<td style="text-align:left;color: black !important;background-color: gray !important;border-left:1px solid;border-right:1px solid;">
Ethnicity, Gender, Race, Age (subject)
</td>
<td style="text-align:left;color: black !important;background-color: gray !important;border-left:1px solid;border-right:1px solid;">
Age, H1N1 like virus and H3N1 like virus
</td>
<td style="text-align:left;color: black !important;background-color: gray !important;border-left:1px solid;border-right:1px solid;">
NA
</td>
<td style="text-align:left;color: black !important;background-color: gray !important;border-left:1px solid;border-right:1px solid;">
Yes (IK_cell_population, IK_cell_population_marker)
</td>
<td style="text-align:left;color: black !important;background-color: gray !important;border-left:1px solid;border-right:1px solid;">
NA
</td>
</tr>
<tr>
<td style="text-align:left;color: black !important;background-color: gray !important;border-left:1px solid;border-right:1px solid;">
SDY520
</td>
<td style="text-align:left;color: black !important;background-color: gray !important;border-left:1px solid;border-right:1px solid;">
David Hafler
</td>
<td style="text-align:left;color: black !important;background-color: gray !important;border-left:1px solid;border-right:1px solid;">
Yale
</td>
<td style="text-align:left;color: black !important;background-color: gray !important;border-left:1px solid;border-right:1px solid;">
Immunologic and genomic signatures of influenza vaccine response - 2013 (see companion studies SDY63, SDY404, SDY400)
</td>
<td style="text-align:left;color: black !important;background-color: gray !important;border-left:1px solid;border-right:1px solid;">
Project 1: Immunologic and genomic signatures of influenza vaccine response - year4 2013
</td>
<td style="text-align:left;color: black !important;background-color: gray !important;border-left:1px solid;border-right:1px solid;">
Identification of immunologic, gene expression, and genetic loci signatures of vaccine response, and effects of aging and functional status on these signatures.
</td>
<td style="text-align:left;color: black !important;background-color: gray !important;border-left:1px solid;border-right:1px solid;">
Homo sapiens
</td>
<td style="text-align:left;color: black !important;background-color: gray !important;border-left:1px solid;border-right:1px solid;">
Young adults 21-30 years old; older adults &gt;=65 years old
</td>
<td style="text-align:left;color: black !important;background-color: gray !important;border-left:1px solid;border-right:1px solid;">
61
</td>
<td style="text-align:left;color: black !important;background-color: gray !important;border-left:1px solid;border-right:1px solid;">
HAI
</td>
<td style="text-align:left;color: black !important;background-color: gray !important;border-left:1px solid;border-right:1px solid;">
No
</td>
<td style="text-align:left;color: black !important;background-color: gray !important;border-left:1px solid;border-right:1px solid;">
Yes (Hai_result)
</td>
<td style="text-align:left;color: black !important;background-color: gray !important;border-left:1px solid;border-right:1px solid;">
No
</td>
<td style="text-align:left;color: black !important;background-color: gray !important;border-left:1px solid;border-right:1px solid;">
SDY 63, SDY 400, SDY 404
</td>
<td style="text-align:left;color: black !important;background-color: gray !important;border-left:1px solid;border-right:1px solid;">
Ethnicity, Gender, Race, Age (subject)
</td>
<td style="text-align:left;color: black !important;background-color: gray !important;border-left:1px solid;border-right:1px solid;">
NA
</td>
<td style="text-align:left;color: black !important;background-color: gray !important;border-left:1px solid;border-right:1px solid;">
NA
</td>
<td style="text-align:left;color: black !important;background-color: gray !important;border-left:1px solid;border-right:1px solid;">
Yes (IK_cell_population, IK_cell_population_marker)
</td>
<td style="text-align:left;color: black !important;background-color: gray !important;border-left:1px solid;border-right:1px solid;">
NA
</td>
</tr>
<tr>
<td style="text-align:left;color: black !important;background-color: gray !important;border-left:1px solid;border-right:1px solid;">
SDY887
</td>
<td style="text-align:left;color: black !important;background-color: gray !important;border-left:1px solid;border-right:1px solid;">
Cornelia Dekker
</td>
<td style="text-align:left;color: black !important;background-color: gray !important;border-left:1px solid;border-right:1px solid;">
Stanford University
</td>
<td style="text-align:left;color: black !important;background-color: gray !important;border-left:1px solid;border-right:1px solid;">
Defective signaling in aging
</td>
<td style="text-align:left;color: black !important;background-color: gray !important;border-left:1px solid;border-right:1px solid;">
In an effort to identify benchmarks of immunological health, influenza vaccination was used in 10 young (20 to 30 years) and 19 older subjects (60 to 89 years) as models for strong and weak immune responses, respectively.
</td>
<td style="text-align:left;color: black !important;background-color: gray !important;border-left:1px solid;border-right:1px solid;">
To assess variability in immune features between young and old and among older adults
</td>
<td style="text-align:left;color: black !important;background-color: gray !important;border-left:1px solid;border-right:1px solid;">
Homo sapiens
</td>
<td style="text-align:left;color: black !important;background-color: gray !important;border-left:1px solid;border-right:1px solid;">
Healthy and ambulatory
</td>
<td style="text-align:left;color: black !important;background-color: gray !important;border-left:1px solid;border-right:1px solid;">
26
</td>
<td style="text-align:left;color: black !important;background-color: gray !important;border-left:1px solid;border-right:1px solid;">
FCM
</td>
<td style="text-align:left;color: black !important;background-color: gray !important;border-left:1px solid;border-right:1px solid;">
No
</td>
<td style="text-align:left;color: black !important;background-color: gray !important;border-left:1px solid;border-right:1px solid;">
NA
</td>
<td style="text-align:left;color: black !important;background-color: gray !important;border-left:1px solid;border-right:1px solid;">
No
</td>
<td style="text-align:left;color: black !important;background-color: gray !important;border-left:1px solid;border-right:1px solid;">
No
</td>
<td style="text-align:left;color: black !important;background-color: gray !important;border-left:1px solid;border-right:1px solid;">
Ethnicity, Gender, Race, Age (subject)
</td>
<td style="text-align:left;color: black !important;background-color: gray !important;border-left:1px solid;border-right:1px solid;">
20-30 years; 60-89 years
</td>
<td style="text-align:left;color: black !important;background-color: gray !important;border-left:1px solid;border-right:1px solid;">
0, 28 days
</td>
<td style="text-align:left;color: black !important;background-color: gray !important;border-left:1px solid;border-right:1px solid;">
Yes (IK_cell_population, IK_cell_population_marker)
</td>
<td style="text-align:left;color: black !important;background-color: gray !important;border-left:1px solid;border-right:1px solid;">
NA
</td>
</tr>
<tr>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
SDY180
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
A. Karolina Palucka
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
Baylor Reasearch Institute
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
Systems scale interactive exploration reveals quantitative and qualitative differences in response to 2009-2010 Fluzone influenza vaccine and pneumococcal vaccine
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
Systems approach to study immune response to seasonal influenza and 23-valent pneumoccocal vaccination in healthy adults.
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
Our aim is to apply systems biology approaches to study immune responses to vaccination with seasonal influenza and 23-valent pneumococcal vaccine in healthy adults. This in turn will permit us to define vaccine responders and non-responders and develop biomarker signatures predictive of vaccine response.
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
Homo sapiens
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
healthy adults, aged 18 to 64 years; exclusion: pregnancy, active allergy symptoms, or vaccinations within the previous 2 months.
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
46
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
Luminex xMAP; HAI; Virus Neutralization for Neutralizing Antibody Titer; FCM; DNA microarray; Nanostring
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
Yes
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
Yes
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
Yes
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
No
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
Ethnicity, Gender, Race, Age (subject)
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
Multiple
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
Multiple
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
Yes (IK_cell_population, IK_cell_population_marker)
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
NA
</td>
</tr>
<tr>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
SDY74
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
A. Karolina Palucka
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
Baylor Reasearch Institute
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
Systems Biology Approach to Analysis of 2010-11 TIV Fluzone Influenza Vaccine Response in Healthy Individuals (see companion studies SDY301, SDY296)
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
This study will measure the immune response to the influenza vaccine The long-term goal is to develop improved vaccines to infectious diseases such as influenza. Blood will be collected from patients at several visits before and after vaccination. The blood will be used in a series of immunological tests to measure the strength and breadth of immune response. These assays may include T cell and B cell activation assays, microarray testing, Epimax, Epigen, and flow cytometry.
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
To measure immune responses to vaccination with flu vaccine in healthy adult subjects.
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
Homo sapiens
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
18-64 years of age; fluzone group; pneumovax group
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
12
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
FCM; DNA microarray
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
Yes
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
No
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
Illumina bead array
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
SDY 301, SDY 296
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
Ethnicity, Gender, Race, Age (subject)
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
NA
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
Multiple
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
Yes (IK_cell_population, IK_cell_population_marker)
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
NA
</td>
</tr>
<tr>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
SDY296
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
A. Karolina Palucka
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
Baylor Reasearch Institute
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
Systems Biology Approach to Analysis of 2011-12 TIV Fluzone Influenza Vaccine Response in Healthy Individuals (see companion studies SDY74, SDY301)
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
This project will contribute to the overall vision and goals of this U19 by analyzing the immune response to Flu vaccination in healthy individuals. The knowledge generated in this Project will be transferred to Projects 3-5 where immune effects of vaccination will be studied in patients with underlying immune system alterations.
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
To measure immune responses to vaccination with flu vaccine in healthy adult subjects.
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
Homo sapiens
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
healthy adults between the ages of 21 and 58 will receive seasonal TIV and followed up for 3 vaccine seasons
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
45
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
HAI; Virus Neutralization; FCM, DNA microarray; RNA-seq
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
Yes
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
Yes
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
Yes
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
SDY 74, SDY 301
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
Ethnicity, Gender, Race, Age (subject)
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
NA
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
Multiple
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
Yes (IK_cell_population, IK_cell_population_marker)
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
NA
</td>
</tr>
<tr>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
SDY301
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
A. Karolina Palucka
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
Baylor Reasearch Institute
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
Systems Biology Approach to Analysis of 2012-13 TIV Fluzone Influenza Vaccine Response in Healthy Individuals (see companion studies SDY74, SDY296)
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
This project will contribute to the overall vision and goals of this U19 by analyzing the immune response to Flu vaccination in healthy individuals. The knowledge generated in this Project will be transferred to Projects 3-5 where immune effects of vaccination will be studied in patients with underlying immune system alterations.
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
To measure immune responses to vaccination with flu vaccine in healthy adult subjects.
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
Homo sapiens
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
healthy adults between the ages of 21 and 58 will receive seasonal TIV and followed up for 3 vaccine seasons
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
40
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
HAI; Virus Neutralization; FCM, DNA microarray; RNA-seq
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
Yes
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
Yes
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
Yes
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
SDY 74, SDY 296
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
Ethnicity, Gender, Race, Age (subject)
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
NA
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
Multiple
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
Yes (IK_cell_population, IK_cell_population_marker)
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
NA
</td>
</tr>
<tr>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
SDY272
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
Hildegund Ertl
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
The Wistar Institute
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
Humoral responses to Influenza vaccination in aged populations - Year 1 2011 (See companion studies SDY622 2012, SDY648 2013, SDY739 2014, SDY819 2015)
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
The purpose of this study was to measure the antibody responses to the Trivalent Inactivated influenza Vaccine(TIV) in young and aged subjects
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
To measure the antibody responses to Trivalent Inactivated Influenza vaccination in young and aged human subjects - specifically neutralizing antibodies and binding isotypes
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
Homo sapiens
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
Healthy young individuals 30-40 years of age and Aged &gt;=65 years of age
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
46
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
ELISA; Virus Neutralization; FCM
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
Yes
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
Yes (neut_ab_titer)
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
No
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
SDY 622, SDY 648, SDY 739, SDY 819
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
Ethnicity, Gender, Race, Age (subject)
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
NA
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
0, 10, 30, 60
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
Yes (IK_cell_population, IK_cell_population_marker)
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
NA
</td>
</tr>
<tr>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
SDY622
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
Hildegund Ertl and E. John Wherry
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
The Wistar Institute and University of Pennsylvania
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
Humoral responses to Influenza vaccination in aged populations - Year 2 2012 (See companion studies SDY272 2011, SDY648 2013, SDY739 2014, SDY819 2015)
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
The purpose of this study was to measure the B cell responses to the Trivalent Inactivated influenza Vaccine(TIV) in young and aged subjects, and measure their different B cell subsets.
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
To measure the antibody responses to Trivalent Inactivated Influenza vaccination in young and aged human subjects - specifically neutralizing antibodies and binding isotypes
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
Homo sapiens
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
Exclusion: Immunosuppression resulting from disease
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
63
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
ELISA; Virus Neutralization; FCM; DNA microarray
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
Yes
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
Yes (neut_ab_titer)
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
Illumina bead array
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
SDY 272, SDY 648, SDY 739, SDY 819
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
Ethnicity, Gender, Race, Age (subject)
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
30-40 years; &gt;=65 years
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
0, 7, 14 Days
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
Yes (IK_cell_population, IK_cell_population_marker)
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
NA
</td>
</tr>
<tr>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
SDY648
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
E. John Wherry and Hildegund Ertl
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
University of Pennsylvania and the Wistar Institute
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
Humoral responses to Influenza vaccination in aged populations - Year 3 2013 (See companion studies SDY272 2011, SDY622 2012, SDY739 2014, SDY819 2015)
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
The purpose of this study was to measure the B celland T cell responses to the Trivalent Inactivated influenza Vaccine(TIV) in young and aged subjects, and measure their different B cell subsets.
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
To measure the antibody responses to Trivalent Inactivated Influenza vaccination in young and aged human subjects - specifically neutralizing antibodies and binding isotypes
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
Homo sapiens
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
Exclusion: Immunosuppression resulting from disease
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
63
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
ELISA; Virus Neutralization; FCM; DNA microarray
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
Yes
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
Yes (neut_ab_titer)
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
Illumina bead array
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
SDY 272, SDY 622, SDY 648, SDY 819
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
Ethnicity, Gender, Race, Age (subject)
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
30-40 years; &gt;=65 years
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
0, 7, 28 Days
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
Yes (IK_cell_population, IK_cell_population_marker)
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
NA
</td>
</tr>
<tr>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
SDY739
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
Hildegund Ertl
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
The Wistar Institute
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
Humoral responses to Influenza vaccination in aged populations - Year 4 2014 (See companion studies SDY272 2011, SDY622 2012, SDY648 2013, SDY819 2015)
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
The purpose of this study was to measure the B celland T cell responses to the Trivalent Inactivated influenza Vaccine(TIV) in young and aged subjects, and measure their different B cell subsets.
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
To measure the antibody responses to Trivalent Inactivated Influenza vaccination in young and aged human subjects - specifically neutralizing antibodies and binding isotypes
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
Homo sapiens
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
Exclusion: Immunosuppression resulting from disease
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
65
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
ELISA; Virus Neutralization; FCM; DNA microarray
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
Yes
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
Yes (neut_ab_titer)
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
Illumina bead array
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
SDY 272, SDY 622, SDY 648, SDY 819
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
Ethnicity, Gender, Race, Age (subject)
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
30-40 years; &gt;=65 years
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
0, 7, 28 Days
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
Yes (IK_cell_population, IK_cell_population_marker)
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
NA
</td>
</tr>
<tr>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
SDY819
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
Hildegund Ertl
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
The Wistar Institute
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
Humoral responses to Influenza vaccination in aged populations - Year 5 2015 (See companion studies SDY272 2011, SDY622 2012, SDY648 2013, SDY739 2014)
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
The purpose of this study was to measure the B cell and T cell responses to the Trivalent Inactivated influenza Vaccine(TIV) in young and aged subjects, and measure their different B cell subsets.
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
To measure the antibody responses to Trivalent Inactivated Influenza vaccination in young and aged human subjects - specifically neutralizing antibodies and binding isotypes
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
Homo sapiens
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
Exclusion: Immunosuppression resulting from disease
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
45
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
ELISA; Virus Neutralization; FCM
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
Yes
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
Yes (neut_ab_titer)
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
No
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
SDY 272, SDY 622, SDY 648, SDY 739
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
Ethnicity, Gender, Race, Age (subject)
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
30-40 years; &gt;=65 years
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
0, 7, 28 Days
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
Yes (IK_cell_population, IK_cell_population_marker)
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
NA
</td>
</tr>
<tr>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
SDY144
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
Octavio Ramilo
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
Nationwide Children’s Hospital
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
Systems Biology Approach to Study Influenza Vaccine 2011-12 in Healthy Children (see companion studies SDY364, SDY368, SDY387)
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
To characterize the cellular and transcriptional signatures of response to Flu vaccine in healthy children.
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
<ol style="list-style-type: decimal">
<li>which are the best biomarkers of immune response to influenza vaccine in healthy children; 2) how unique autoimmune backgrounds set the stage for responsiveness/unresponsiveness to vaccines; 3) whether vaccination contributes to increase the breadth of autoimmunity in a disease-specific manner.
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
Homo sapiens
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
Between the ages of 6 months and 18 years; Has not had flu vaccine for this season
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
17
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
FCM (B, Mono, DC, Tfh); DNA Microarray; Virus Neutralization
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
Yes
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
Yes
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
No
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
SDY 364, SDY 368, SDY 387
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
Ethnicity, Gender, Race, Age (subject)
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
NA
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
0, 7, 30
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
Yes (IK_cell_population, IK_cell_population_marker)
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
NA
</td>
</tr>
<tr>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
SDY364
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
Octavio Ramilo
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
Nationwide Children’s Hospital
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
Systems Biology Approach to Study Influenza Vaccine 2012-13 in Healthy Children (see companion studies SDY144, SDY368, SDY387)
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
To characterize the cellular and transcriptional signatures of response to Flu vaccine in healthy children.
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
<ol style="list-style-type: decimal">
<li>which are the best biomarkers of immune response to influenza vaccine in healthy children; 2) how unique autoimmune backgrounds set the stage for responsiveness/unresponsiveness to vaccines; 3) whether vaccination contributes to increase the breadth of autoimmunity in a disease-specific manner.
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
Homo sapiens
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
Between the ages of 6 months and 18 years; Has not had flu vaccine for this season
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
23
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
FCM; HAI; DNA Microarray; Virus Neutralization
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
Yes
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
Yes
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
Illumina bead array
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
SDY 144, SDY 368, SDY 387
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
Ethnicity, Gender, Race, Age (subject)
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
NA
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
0, 7, 30
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
Yes (IK_cell_population, IK_cell_population_marker)
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
NA
</td>
</tr>
<tr>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
SDY368
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
Octavio Ramilo
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
Nationwide Children’s Hospital
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
Systems Biology Approach to Study Influenza Vaccine 2013-14 in Healthy Children (see companion studies SDY364, SDY144, SDY387)
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
To characterize the cellular and transcriptional signatures of response to Flu vaccine in healthy children.
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
<ol style="list-style-type: decimal">
<li>which are the best biomarkers of immune response to influenza vaccine in healthy children; 2) how unique autoimmune backgrounds set the stage for responsiveness/unresponsiveness to vaccines; 3) whether vaccination contributes to increase the breadth of autoimmunity in a disease-specific manner.
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
Homo sapiens
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
Between the ages of 6 months and 18 years; Has not had flu vaccine for this season
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
22
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
FCM; HAI; DNA Microarray; Virus Neutralization
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
Yes
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
Yes
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
Illumina bead array
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
SDY 144, SDY 364, SDY 387
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
Ethnicity, Gender, Race, Age (subject)
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
NA
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
0, 7, 28
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
Yes (IK_cell_population, IK_cell_population_marker)
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
NA
</td>
</tr>
<tr>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
SDY387
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
Octavio Ramilo
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
Nationwide Children’s Hospital
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
Systems Biology Approach to Study Influenza Vaccine 2010-11 in Healthy Children (see companion studies SDY144, SDY368, SDY387)
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
To characterize the cellular and transcriptional signatures of response to Flu vaccine in healthy children.
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
<ol style="list-style-type: decimal">
<li>which are the best biomarkers of immune response to influenza vaccine in healthy children; 2) how unique autoimmune backgrounds set the stage for responsiveness/unresponsiveness to vaccines; 3) whether vaccination contributes to increase the breadth of autoimmunity in a disease-specific manner.
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
Homo sapiens
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
Between the ages of 6 months and 18 years; Has not had flu vaccine for this season
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
22
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
FCM; HAI; DNA Microarray; Virus Neutralization
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
Yes
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
Yes
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
Illumina bead array
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
SDY 144, SDY 364, SDY 368
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
Ethnicity, Gender, Race, Age (subject)
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
NA
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
0, 7, 30, 90, 180
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
Yes (IK_cell_population, IK_cell_population_marker)
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
NA
</td>
</tr>
<tr>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
SDY522
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
Octavio Ramilo
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
Nationwide Children’s Hospital
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
Differences in Antibody Responses Between Trivalent Inactivated Influenza Vaccine and Live Attenuated Influenza Vaccine (2011-12) Correlate With the Kinetics and Magnitude of Interferon Signaling in Children (see companion studies SDY144, SDY360)
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
To characterize the cellular and transcriptional signatures of response to Flu vaccine in healthy children.
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
<ol style="list-style-type: decimal">
<li>which are the best biomarkers of immune response to influenza vaccine in healthy children; 2) how unique autoimmune backgrounds set the stage for responsiveness/unresponsiveness to vaccines; 3) whether vaccination contributes to increase the breadth of autoimmunity in a disease-specific manner.
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
Homo sapiens
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
Between the ages of 6 months and 18 years; Has not had flu vaccine for this season
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
20
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
DNA microarray; Virus Neutralization; HAI; FCM
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
There is no SDY360 available at ImmPort
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
NA
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
NA
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
NA
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
NA
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
NA
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
NA
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
NA
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
NA
</td>
</tr>
<tr>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
SDY33
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
Christian Larsen
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
Emory Transplant Center
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
Impact of immunosuppressive regimens on protective immunity in renal transplant recipients
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
A prospective longitudinal study to determine biological mechanisms that underlie the immunosuppressed state associated with immunosuppressive regimens after renal transplantation.
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
<ol style="list-style-type: decimal">
<li>To determine the effects of chronic immunosuppressive therapies on adaptive immunity: Effects on the phenotype and functional properties of T cell and B cell subsets and antigen-specific T cells. 2. To determine the effects of chronic immunosuppressive therapies on innate immunity, dendritic cell phenotype, function and TLR signaling. 3. To define the transcriptional signatures associated with specific immunosuppressive regimens.
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
Homo sapiens
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
Denovo transplant; with/without induction; Tacrolimus/Sirolimus/Efalizumab maintenance; healthy subjects age, gender and race matched to patients
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
116
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
FCM; HLA Typing; DNA microarray; ELISPOT
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
Yes
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
No
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
No
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
No
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
Ethnicity, Gender, Race, Age (subject)
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
Multiple
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
Multiple
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
Yes (IK_cell_population, IK_cell_population_marker)
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
NA
</td>
</tr>
<tr>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
SDY34
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
Christian Larsen
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
Emory Transplant Center
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
Comparison of immune response to influenza vaccine in transplant patients and healthy controls
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
To determine the effects of chronic immunosuppressive therapies on the magnitude and character of the adaptive immune response to influenza vaccination.
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
<ol style="list-style-type: decimal">
<li>To determine the effects of chronic immunosuppressive therapies on the magnitude and character of the adaptive immune response to influenza vaccination. 2. To determine the effects of chronic immunosuppressive therapies on innate immunity during response to influenza vaccination. 3. To define the transcriptional signatures after influenza vaccination with chronic immunosuppressive therapies
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
Homo sapiens
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
Subject had renal transplant 6 months prior to start of study; Subject receiving immunosuppressive therapy; Healthy subjects not receiving immunosuppressant drugs and are age, gender and race matched to patients.
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
97
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
FCM; HLA Typing; DNA microarray
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
Yes
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
No
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
.CEL files
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
No
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
Ethnicity, Gender, Race, Age (subject)
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
Multiple
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
Multiple
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
Yes (IK_cell_population, IK_cell_population_marker)
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
NA
</td>
</tr>
<tr>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
SDY167
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
Julie Ledgerwood
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
Vaccine Research Center, National Institute of Allergy and Infectious Diseases (NIAID)
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
VRC304 - A Phase I Study of the Safety and Immunogenicity of a Recombinant DNA Plasmid Vaccine (VRC-AVIDNA036-00-VP) Encoding for the Influenza Virus H5 Hemagglutinin Protein in Healthy Adults
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
VRC304 - A Phase I, double-blind, placebo-controlled, randomized, dose escalation study to evaluate safety, tolerability, and immunogenicity of a recombinant DNA vaccine against the influenza virus hemagglutinin H5.
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
<ol style="list-style-type: decimal">
<li>To evaluate the safety and tolerability in humans of VRC-AVIDNA036-00-VP at a dose of 1 mg and 4 mg administered intramuscularly using a needle-free injection system. 2. To evaluate whether VRC-AVIDNA036-00-VP at a dose of 1 mg and 4 mg induces antibodies to H5 HA as assessed by an HAI assay at Day 0 and Week 12. 3. To evaluate the immunogenicity of VRC-AVIDNA036-00-VP at a dose of 1 mg and 4 mg administered intramuscularly using a needle-free injection system as indicated by intracellular cytokine staining, ELISpot, neutralizing antibody assay, HAI to H1 or H3 or other immunological assays at intervals between Day 0 and Week 42.
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
Homo sapiens
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
18-60 years old; In good general health without clinically significant medical history
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
45
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
ELISA; HAI; ELISPOT; Virus Neutralization; FCM
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
Yes
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
Yes (neut_ab_titer)
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
No
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
No
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
Ethnicity, Gender, Race, Age (subject)
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
4mg vaccine, 1mg vaccine, placebo
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
Multiple
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
Yes (IK_cell_population, IK_cell_population_marker)
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
NA
</td>
</tr>
<tr>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
SDY314
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
Mark Davis
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
Stanford University
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
T cell responses to H1N1v and a longitudinal study of seasonal influenza vaccination (TIV) - 2008 (See companion studies SDY315 2012 / SDY312 2009 / SDY311 2010 / SDY112 2011)
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
Systems biology approach to examine effects of seasonal flu vaccination in adults of different ages on gene expression, cytokine stimulation and serum cytokines with parameters such as immune senescence to uncover new markers and mechanisms behind failure of immune function in many older people.
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
<ol style="list-style-type: decimal">
<li>Compare lymphocyte responses at Days 6-8 and the lymphocyte and serology responses at Day 28 post-immunization following administration of seasonal trivalent inactivated influenza vaccine. 2. Evaluate changes in cytokine profile in the immune response (CD4, CD8, gamma-delta cells, B cell responses) from Day 0 to Day 6-8 for T cells and antibody-secreting cells (ASCs). 3. Evaluate changes in cytokine profile in the immune response (CD4, CD8, gamma-delta cells, B cell, and serology responses) from Day 0 to Day 28 for HAI responses. 4. Evaluate any potential gene expression signatures either at Day 0 or during the early response period Day 6-8 that are associated with immune senescence, potentially providing insight into mechanism. 5. Compare cell specific gene expression differences between age groups for both whole blood and whole PBMC. 6. Determine the effect of cell subset frequency variation on serum cytokine abundance. 7. Evaluate CMV and EBV seroreactivity at Day 0 and additional timepoints throughout the study as able.
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
Homo sapiens
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
18-30 year old adults; 60-79 year old adults; 80-90 year old adults; immunized intramuscularly with Fluzone (TIV)
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
92
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
DNA microarray; HAI; HLA typing; Virus Neutralization; FCM
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
Yes
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
Yes (Hai_result)
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
Illumina bead array
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
SDY 315, SDY 312, SDY 311, SDY 112
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
Ethnicity, Gender, Race, Age (subject)
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
Age groups A, B and C
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
0, 28 Days
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
Yes (IK_cell_population, IK_cell_population_marker)
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
NA
</td>
</tr>
<tr>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
SDY312
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
Mark Davis
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
Stanford University
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
T cell responses to H1N1v and a longitudinal study of seasonal influenza vaccination (TIV) - 2009 (See companion studies SDY315 2012 / SDY314 2008 / SDY311 2010 / SDY112 2011)
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
Systems biology approach to examine effects of seasonal flu vaccination in adults of different ages on gene expression, cytokine stimulation and serum cytokines with parameters such as immune senescence to uncover new markers and mechanisms behind failure of immune function in many older people.
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
<ol style="list-style-type: decimal">
<li>Compare lymphocyte responses at Days 6-8 and the lymphocyte and serology responses at Day 28 post-immunization following administration of seasonal trivalent inactivated influenza vaccine. 2. Evaluate changes in cytokine profile in the immune response (CD4, CD8, gamma-delta cells, B cell responses) from Day 0 to Day 6-8 for T cells and antibody-secreting cells (ASCs). 3. Evaluate changes in cytokine profile in the immune response (CD4, CD8, gamma-delta cells, B cell, and serology responses) from Day 0 to Day 28 for HAI responses. 4. Evaluate any potential gene expression signatures either at Day 0 or during the early response period Day 6-8 that are associated with immune senescence, potentially providing insight into mechanism. 5. Compare cell specific gene expression differences between age groups for both whole blood and whole PBMC. 6. Determine the effect of cell subset frequency variation on serum cytokine abundance. 7. Evaluate CMV and EBV seroreactivity at Day 0 and additional timepoints throughout the study as able.
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
Homo sapiens
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
18-30 year old adults; 60-79 year old adults; 80-90 year old adults; immunized intramuscularly with Fluzone (TIV)
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
84
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
DNA microarray; HAI; Luminex xMAP for serum cytokine quantification; FCM (phos and phenotyping)
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
Yes
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
Yes (Hai_result)
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
Illumina bead array
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
SDY 315, SDY 314, SDY 311, SDY 112
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
Ethnicity, Gender, Race, Age (subject)
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
Age groups A, B and C
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
0, 28 Days
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
Yes (IK_cell_population, IK_cell_population_marker)
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
NA
</td>
</tr>
<tr>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
SDY311
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
Mark Davis
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
Stanford University
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
T cell responses to H1N1v and a longitudinal study of seasonal influenza vaccination (TIV) - 2010 (See companion studies SDY315 2012 / SDY312 2009 / SDY314 2008 / SDY112 2011)
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
Systems biology approach to examine effects of seasonal flu vaccination in adults of different ages on gene expression, cytokine stimulation and serum cytokines with parameters such as immune senescence to uncover new markers and mechanisms behind failure of immune function in many older people.
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
<ol style="list-style-type: decimal">
<li>Compare lymphocyte responses at Days 6-8 and the lymphocyte and serology responses at Day 28 post-immunization following administration of seasonal trivalent inactivated influenza vaccine. 2. Evaluate changes in cytokine profile in the immune response (CD4, CD8, gamma-delta cells, B cell responses) from Day 0 to Day 6-8 for T cells and antibody-secreting cells (ASCs). 3. Evaluate changes in cytokine profile in the immune response (CD4, CD8, gamma-delta cells, B cell, and serology responses) from Day 0 to Day 28 for HAI responses. 4. Evaluate any potential gene expression signatures either at Day 0 or during the early response period Day 6-8 that are associated with immune senescence, potentially providing insight into mechanism. 5. Compare cell specific gene expression differences between age groups for both whole blood and whole PBMC. 6. Determine the effect of cell subset frequency variation on serum cytokine abundance. 7. Evaluate CMV and EBV seroreactivity at Day 0 and additional timepoints throughout the study as able.
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
Homo sapiens
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
18-30 year old adults; 60-79 year old adults; 80-90 year old adults; immunized intramuscularly with Fluzone (TIV)
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
76
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
DNA microarray; HAI; Luminex xMAP for serum cytokine quantification; CyTOF; FCM (phos)
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
Yes
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
Yes
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
Illumina bead array
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
SDY 315, SDY 312, SDY 314, SDY 112
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
Ethnicity, Gender, Race, Age (subject)
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
Age groups A, B and C
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
0, 7, 28 Days
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
Yes (IK_cell_population, IK_cell_population_marker)
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
NA
</td>
</tr>
<tr>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
SDY112
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
Mark Davis
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
Stanford University
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
T cell responses to H1N1v and a longitudinal study of seasonal influenza vaccination (TIV) - 2011 (See companion studies SDY311 2010 / SDY312 2009 / SDY314 2008 / SDY315 2012)
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
Systems biology approach to examine effects of seasonal flu vaccination in adults of different ages on gene expression, cytokine stimulation and serum cytokines with parameters such as immune senescence to uncover new markers and mechanisms behind failure of immune function in many older people.
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
<ol style="list-style-type: decimal">
<li>Compare lymphocyte responses at Days 6-8 and the lymphocyte and serology responses at Day 28 post-immunization following administration of seasonal trivalent inactivated influenza vaccine. 2. Evaluate changes in cytokine profile in the immune response (CD4, CD8, gamma-delta cells, B cell responses) from Day 0 to Day 6-8 for T cells and antibody-secreting cells (ASCs). 3. Evaluate changes in cytokine profile in the immune response (CD4, CD8, gamma-delta cells, B cell, and serology responses) from Day 0 to Day 28 for HAI responses. 4. Evaluate any potential gene expression signatures either at Day 0 or during the early response period Day 6-8 that are associated with immune senescence, potentially providing insight into mechanism. 5. Compare cell specific gene expression differences between age groups for both whole blood and whole PBMC. 6. Determine the effect of cell subset frequency variation on serum cytokine abundance. 7. Evaluate CMV and EBV seroreactivity at Day 0 and additional timepoints throughout the study as able.
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
Homo sapiens
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
18-30 year old adults; 60-79 year old adults; 80-100 year old adults; immunized intramuscularly with Fluzone (TIV)
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
93
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
DNA microarray; HAI; Luminex xMAP for serum cytokine quantification; CyTOF; FCM (phos)
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
Yes
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
Yes
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
.CEL files
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
SDY 311, SDY 312, SDY 314, SDY 315
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
Ethnicity, Gender, Race, Age (subject)
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
Age groups A, B and C
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
0, 7, 28, 180
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
Yes (IK_cell_population, IK_cell_population_marker)
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
NA
</td>
</tr>
<tr>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
SDY315
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
Mark Davis
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
Stanford University
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
T cell responses to H1N1v and a longitudinal study of seasonal influenza vaccination (TIV) - 2012 (See companion studies SDY311 2010 / SDY312 2009 / SDY314 2008 / SDY112 2011)
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
Systems biology approach to examine effects of seasonal flu vaccination in adults of different ages on gene expression, cytokine stimulation and serum cytokines with parameters such as immune senescence to uncover new markers and mechanisms behind failure of immune function in many older people.
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
<ol style="list-style-type: decimal">
<li>Compare lymphocyte responses at Days 6-8 and the lymphocyte and serology responses at Day 28 post-immunization following administration of seasonal trivalent inactivated influenza vaccine. 2. Evaluate changes in cytokine profile in the immune response (CD4, CD8, gamma-delta cells, B cell responses) from Day 0 to Day 6-8 for T cells and antibody-secreting cells (ASCs). 3. Evaluate changes in cytokine profile in the immune response (CD4, CD8, gamma-delta cells, B cell, and serology responses) from Day 0 to Day 28 for HAI responses. 4. Evaluate any potential gene expression signatures either at Day 0 or during the early response period Day 6-8 that are associated with immune senescence, potentially providing insight into mechanism. 5. Compare cell specific gene expression differences between age groups for both whole blood and whole PBMC. 6. Determine the effect of cell subset frequency variation on serum cytokine abundance. 7. Evaluate CMV and EBV seroreactivity at Day 0 and additional timepoints throughout the study as able.
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
Homo sapiens
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
18-30 year old adults; 60-79 year old adults; 80-90 year old adults; immunized intramuscularly with Fluzone (TIV)
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
74
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
DNA microarray; HAI; Luminex xMAP for serum cytokine quantification; CyTOF, FCM (phos)
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
Yes
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
Yes
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
.CEL files
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
SDY 311, SDY 312, SDY 314, SDY 112
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
Ethnicity, Gender, Race, Age (subject)
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
Age groups A, B and C
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
0, 28 Days
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
Yes (IK_cell_population, IK_cell_population_marker)
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
NA
</td>
</tr>
<tr>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
SDY514
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
Mark Davis
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
Stanford University
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
Monozygotic and Dizygotic Twin Pair T-Cell Responses to Influenza Vaccination 2009
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
Evaluate the variation in immune response between individuals and assess whether it changes as a function of age and similarity in genetic and environmental background (by comparing differences between monozygotic and dizygotic twin pairs of different ages).
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
test T-Cell Responses to Influenza Vaccination
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
Homo sapiens
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
Genrally healthy and ambulatory children and adults
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
78
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
HAI; FCM; Luminex xMAP for serum protein quantification
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
Yes
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
Yes
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
No
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
NA
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
Ethnicity, Gender, Race, Age (subject)
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
8-17 year old monozygotic twins; 18-30 year old monozygotic twins; 18-30 year old dizygotic twin; 40-49 year old monozygotic twin; 40-49 year old dizygotic twin; 70-100 year old monozygotic or dizygotic twin; 70-100 year old non-twins
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
0, 9, 28 Days
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
Yes (IK_cell_population, IK_cell_population_marker)
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
NA
</td>
</tr>
<tr>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
SDY515
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
Mark Davis
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
Stanford University
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
Monozygotic and Dizygotic Twin Pair T-Cell Responses to Influenza Vaccination 2010
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
Evaluate the variation in immune response between individuals and assess whether it changes as a function of age and similarity in genetic and environmental background (by comparing differences between monozygotic and dizygotic twin pairs of different ages).
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
Compare lymphocyte responses at Days 7-10 and the lymphocyte and serology responses at Day 28 post-immunization following annual administration of the influenza vaccines; Evaluate changes in cytokine profile in the immune response (CD4, CD8,and B cell responses) from Day 0 to Day 7-10 for T cells and antibody-secreting cells (ASCs); Evaluate changes in cytokine profile in the immune response from Day 0 to Day 28 for HAI responses to the vaccine antigens; Evaluate any potential gene expression signatures either at Day 0 or during the early response period Day 7-10 that are associated with immune senescence, potentially providing insight into mechanism; Identify age-specific biomarkers or clusters of markers in general and especially those that are predictive of immune sufficiency or insufficiency.
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
Homo sapiens
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
Genrally healthy and ambulatory children and adults
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
84
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
HAI; FCM; CyTOF; Luminex xMAP for serum protein quantification
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
Yes
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
Yes
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
No
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
NA
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
Ethnicity, Gender, Race, Age (subject)
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
8-17 year old monozygotic twins; 18-30 year old monozygotic twins; 18-30 year old dizygotic twin; 40-59 year old monozygotic twin; 40-59 year old dizygotic twin; 70-100 year old monozygotic ; Control
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
0, 7, 28 Days
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
Yes (IK_cell_population, IK_cell_population_marker)
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
NA
</td>
</tr>
<tr>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
SDY519
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
Mark Davis
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
Stanford University
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
Monozygotic and Dizygotic Twin Pair T-Cell Responses to Influenza Vaccination 2011
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
Evaluate the variation in immune response between individuals and assess whether it changes as a function of age and similarity in genetic and environmental background (by comparing differences between monozygotic and dizygotic twin pairs of different ages).
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
Compare lymphocyte responses at Days 7-10 and the lymphocyte and serology responses at Day 28 post-immunization following annual administration of the influenza vaccines; Evaluate changes in cytokine profile in the immune response (CD4, CD8,and B cell responses) from Day 0 to Day 7-10 for T cells and antibody-secreting cells (ASCs) ; Evaluate changes in cytokine profile in the immune response from Day 0 to Day 28 for HAI responses to the vaccine antigens; Evaluate any potential gene expression signatures either at Day 0 or during the early response period Day 7-10 that are associated with immune senescence, potentially providing insight into mechanism; Identify age-specific biomarkers or clusters of markers in general and especially those that are predictive of immune sufficiency or insufficiency.
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
Homo sapiens
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
Genrally healthy and ambulatory children and adults
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
63
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
HAI; FCM; CyTOF; Luminex xMAP for serum protein quantification
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
Yes
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
Yes
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
No
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
NA
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
Ethnicity, Gender, Race, Age (subject)
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
18-30 year old monozygotic twins; 18-30 year old dizygotic twin; 40-64 year old monozygotic twin; 40-64 year old dizygotic twin; 65-100 year old monozygotic ; Control
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
0, 7, 28 Days
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
Yes (IK_cell_population, IK_cell_population_marker)
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
NA
</td>
</tr>
<tr>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
SDY212
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
Mark Davis
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
Stanford University
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
Apoptosis and other immune biomarkers predict influenza vaccine (TIV 2008) responsiveness
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
In an effort to indentify benchmarks of immunological health, influenza vaccination was used in 30 young (20 to 30 years) and 59 older subjects (60 to 89 years) as models for strong and weak immune responses, respectively.
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
To determine if biomarkers present in blood can be used to predict serological responses to influenza vaccine prior to vaccine administration
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
Homo sapiens
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
Yong aged 20-30; Old aged 60-89; Fluzone vaccinated
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
91
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
HAI; DNA microarray of whole blood; Protein microarray (HA); FCM (leukocyte subsets); Luminex xMAP for serum cytokine quantification)
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
Yes
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
Yes
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
No
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
No
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
Ethnicity, Gender, Race, Age (subject)
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
Old vs young
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
0, 28 days
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
Yes (IK_cell_population, IK_cell_population_marker)
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
NA
</td>
</tr>
<tr>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
SDY67
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
Gregory Poland
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
Mayo Clinic
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
Bioinformatics Approach to 2010-2011 TIV Influenza A/H1N1 Vaccine Immune Profiling
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
Aim 1: Characterize Immune Profiles Over Time, Aim 2: Correlate Immune Profiles with Vaccine Immunogenicity,Aim 3: Replication of Immune Profiles and Verification of Models
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
Aim 1: Characterize Immune Profiles Over Time, Aim 2: Correlate Immune Profiles with Vaccine Immunogenicity,Aim 3: Replication of Immune Profiles and Verification of Models
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
Homo sapiens
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
50-74 years old healthy adults
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
159
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
ELISPOT; PCR; FCM (B cell; T cell; Treg; Innate); RNA seq; Virus Neutralization; HAI; DNA methylation profiling; Mass Spectrometry
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
Yes
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
Yes
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
Yes (RNA-seq)
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
No
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
Ethnicity, Gender, Race, Age (subject)
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
NA
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
0, 3, 28, 75 Days
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
Yes (IK_cell_population, IK_cell_population_marker)
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
NA
</td>
</tr>
<tr>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
SDY196-SDY201
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
Linda Thompson
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
Oklahoma Medical Research Foundation (OMRF)
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
Responses to Influenza Vaccination in Systemic Lupus
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
Compare the major components of the normal immune response to flu vaccination in SLE patients and control subjects in order to identify abnormalities in SLE group of immunocompromised individuals.
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
To understand why many patients with systemic lupus erythematosus (SLE) fail to make adequate responses to immunization with the influenza vaccine.
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
Homo sapiens
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
Meet the American College of Rheumatology classification criteria for SLE and receiving an injectable influenza vaccination; Equal number of gender, race, and age within 5 years unaffected controls receiving injectable influenza vaccination.
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
Year 1: 62; Year 2: 63; Year 3: 74; Year 4: 69; Year 5: 73; Year 6: 34.
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
FCM; HAI; ELISPOT; ELISA
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
NA
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
NA
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
NA
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
NA
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
NA
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
NA
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
NA
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
NA
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
NA
</td>
</tr>
<tr>
<td style="text-align:left;color: black !important;background-color: gray !important;border-left:1px solid;border-right:1px solid;">
SDY80
</td>
<td style="text-align:left;color: black !important;background-color: gray !important;border-left:1px solid;border-right:1px solid;">
John Tsang
</td>
<td style="text-align:left;color: black !important;background-color: gray !important;border-left:1px solid;border-right:1px solid;">
CHI of NIH
</td>
<td style="text-align:left;color: black !important;background-color: gray !important;border-left:1px solid;border-right:1px solid;">
Cellular and molecular characterization of the immune response in healthy NIH employees at baseline and after immunization with the H1N1 or seasonal influenza vaccines
</td>
<td style="text-align:left;color: black !important;background-color: gray !important;border-left:1px solid;border-right:1px solid;">
The Center for Human Immunology, Autoimmunity, and Inflammatory Diseases proposes this protocol designed to obtain blood from healthy adult subjects (NIH employees) prior to vaccination and then at various time points after receiving the FDA-licensed seasonal and H1N1 influenza vaccine. These samples will be used to perform a comprehensive and detailed analysis of the immune system at baseline and in response to vaccination. To our knowledge, this protocol will be the first study to characterize the human cellular and molecular immune system parameters, or immunome, in a large number of healthy adults (NIH employees). This information may be useful in designing newer, more effective vaccines to prevent the spread of H1N1 influenza.
</td>
<td style="text-align:left;color: black !important;background-color: gray !important;border-left:1px solid;border-right:1px solid;">
The primary objective of this protocol is to perform a comprehensive and detailed analysis of the cellular and molecular immune responses in healthy adults at baseline, and after vaccination with either the seasonal H1N1 and the influenza vaccines. This will be the first study to systematically characterize the human immunome in a large number of healthy subjects (specifically NIH Employees). Furthermore, we anticipate that this protocol may provide information that may be useful in designing newer, more effective vaccines to prevent the spread of influenza, especially H1N1.
</td>
<td style="text-align:left;color: black !important;background-color: gray !important;border-left:1px solid;border-right:1px solid;">
Homo sapiens
</td>
<td style="text-align:left;color: black !important;background-color: gray !important;border-left:1px solid;border-right:1px solid;">
Healthy 18+ years older NIH employees
</td>
<td style="text-align:left;color: black !important;background-color: gray !important;border-left:1px solid;border-right:1px solid;">
64
</td>
<td style="text-align:left;color: black !important;background-color: gray !important;border-left:1px solid;border-right:1px solid;">
FCM (B,T,mono, DC); ELISPOT; Virus Neturalization; DNA microarray
</td>
<td style="text-align:left;color: black !important;background-color: gray !important;border-left:1px solid;border-right:1px solid;">
No
</td>
<td style="text-align:left;color: black !important;background-color: gray !important;border-left:1px solid;border-right:1px solid;">
No
</td>
<td style="text-align:left;color: black !important;background-color: gray !important;border-left:1px solid;border-right:1px solid;">
No
</td>
<td style="text-align:left;color: black !important;background-color: gray !important;border-left:1px solid;border-right:1px solid;">
No
</td>
<td style="text-align:left;color: black !important;background-color: gray !important;border-left:1px solid;border-right:1px solid;">
Ethnicity, Gender, Race, Age (subject)
</td>
<td style="text-align:left;color: black !important;background-color: gray !important;border-left:1px solid;border-right:1px solid;">
NA
</td>
<td style="text-align:left;color: black !important;background-color: gray !important;border-left:1px solid;border-right:1px solid;">
NA
</td>
<td style="text-align:left;color: black !important;background-color: gray !important;border-left:1px solid;border-right:1px solid;">
Yes (IK_cell_population, IK_cell_population_marker)
</td>
<td style="text-align:left;color: black !important;background-color: gray !important;border-left:1px solid;border-right:1px solid;">
NA
</td>
</tr>
<tr>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
SDY146
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
Ignacio Sanz
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
University of Rochester
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
Immune response evaluation in patients treated with TNF-alpha blockade (anti-TNF)
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
A systematic study of human immune function with the goal of identifying defective mechanisms of immune response in patients treated with TNF-alpha blockade (anti-TNF)
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
<ol style="list-style-type: decimal">
<li>To study the impact of anti-TNF in B-cell homeostasis by analyzing the steady state B-cell populations in anti-TNF patients and controls. 2. To determine the impact of anti-TNF in B-cell responsiveness in vitro. 3. Determine if anti-TNF agents increase the risk of infection in patients with inflammatory arthritis by inhibiting the maturation of monocytes into immature and mature myeloid DC. 4. Determine if anti-TNF agents increase the risk of infection in patients with inflammatory arthritis by altering the function of both mature and immature myeloid DC subsets
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
Homo sapiens
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
PsA patient diagnosed by Moll and Wright criteria; RA patient who has fulfilled 4 of the 1987 American College of Rheumatology revised criteria for RA classification; Healthy with no inflammatory arthitides and not being treated with anti-TNF or other immunomodulating drugs
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
344
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
FCM (B, DC)
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
Yes
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
No
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
No
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
No
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
Ethnicity, Gender, Race, Age (subject)
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
Rheumatoid arthritis and Psoriatic arthritis patients treated with multiple drugs
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
multiple
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
Yes (IK_cell_population, IK_cell_population_marker)
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
NA
</td>
</tr>
<tr>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
SDY416
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
Alan Menter
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
Baylor University Medical Center
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
Study to measure the immune response to the influenza vaccine in patients with chronic plaque psoriasis
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
Interleukin-12 (IL-12) and interleukin-23 are heterodimeric cytokines, with a common p40 subunit and a unique chain (IL-12p35 and IL-23p19). The p40 subunit of both interleukins binds to the transmembrane IL-12 receptor-beta1 (IL-12R ) on the surface of T lymphocytes and natural killer cells. Ustekinumab is a fully human monoclonal antibody, anti-IL12p40, which binds to the p40 subunit of IL-12 and IL-23 with high affinity and specificity, inhibiting the activity of both interleukins. Ustekinumab has proven to be highly effective in the treatment of chronic plaque psoriasis, with up to 76% of patients achieving a 75% reduction in their psoriasis area and severity index (PASI-75).1, It is routinely recommended that psoriasis patients treated with biologic therapies such as ustekinumab be vaccinated annually with the influenza vaccine. We can thus assess the importance of these cytokines in the immune response to vaccination by comparing the immune response to influenza vaccination of psoriasis patients treated with ustekinumab with that of patients who are not receiving this treatment. We will assess gene expression profiles and white blood cell subsets in the blood of psoriasis patients before vaccination and at multiple time-points after vaccination.
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
To accrue a cohort of patients with chronic plaque psoriasis treated with ustekinumab and a control group psoriasis patients treated with topical agents only who will receive the influenza vaccine. To assess and compare the immune response to vaccination in these groups using transcriptional profiling and flow cytometry analysis
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
Homo sapiens
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
Patients aged 18 to 45 years; Chronic plaque psoriasis; Treatment with ustekinumab or topical treatments only or no current psoriasis treatment
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
45
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
ELISA; FCM
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
Yes
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
No
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
No
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
No
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
Age
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
NA
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
0, 7, 14, 28
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
Yes (IK_cell_population, IK_cell_population_marker)
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
NA
</td>
</tr>
<tr>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
SDY369
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
Virginia Pascual
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
Baylor Institute for Immunology Research
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
Systems Biology Approach to Study Influenza Vaccine in Children with Autoimmunity (Juvenile Dermatomyositis JDM) 2011/2012 Cohort (see companion studies SDY376, SDY372, SDY645)
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
Transcriptional profiling of peripheral blood of pediatric patients with juvenile dermatomyositis (JDM) before/after vaccination with seasonal influenza vaccine (Fluzone)
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
This Project will study vaccine responses in sick children. It will address the following questions: 1) which are the best biomarkers of protective immune response to influenza vaccine (in collaboration with Dr. Ramillo’s study for healthy children and here for patients with JDM); 2) how unique autoimmune backgrounds set the stage for responsiveness/unresponsiveness to vaccines; 3) whether vaccination contributes to increase the breadth of autoimmunity in a disease-specific manner. Ultimately, we expect that these studies will shed light on basic aspects of humoral immune responses to vaccines and will permit us to discover biomarkers of response that can be applied to healthy children and to the general population
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
Homo sapiens
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
Subjects with autoimmune disease that are less than or equal to 25 years of age
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
4
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
FCM; DNA microarray; HAI; Virus neutralization
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
Yes
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
Yes (Hai_result)
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
No
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
SDY 376, SDY 372, SDY 645
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
Age
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
Age
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
0, 7, 28, 90, 150
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
Yes (IK_cell_population, IK_cell_population_marker)
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
NA
</td>
</tr>
<tr>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
SDY372
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
Virginia Pascual
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
Baylor Institute for Immunology Research
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
Systems Biology Approach to Study Influenza Vaccine in Children with Autoimmunity (Juvenile Dermatomyositis JDM) 2012/2013 Cohort (see companion studies (SDY369, SDY376, SDY645)
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
Transcriptional profiling of peripheral blood of pediatric patients with juvenile dermatomyositis (JDM) before/after vaccination with seasonal influenza vaccine (Fluzone)
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
This Project will study vaccine responses in sick children. It will address the following questions: 1) which are the best biomarkers of protective immune response to influenza vaccine (in collaboration with Dr. Ramillo’s study for healthy children and here for patients with JDM); 2) how unique autoimmune backgrounds set the stage for responsiveness/unresponsiveness to vaccines; 3) whether vaccination contributes to increase the breadth of autoimmunity in a disease-specific manner. Ultimately, we expect that these studies will shed light on basic aspects of humoral immune responses to vaccines and will permit us to discover biomarkers of response that can be applied to healthy children and to the general population
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
Homo sapiens
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
Subjects with autoimmune disease that are less than or equal to 25 years of age
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
19
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
FCM; DNA microarray; HAI; Virus neutralization
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
Yes
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
Yes (Hai_result)
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
Illumina bead array
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
SDY 369, SDY 376, SDY 645
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
Age
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
Age
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
0, 7, 28, 90
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
Yes (IK_cell_population, IK_cell_population_marker)
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
NA
</td>
</tr>
<tr>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
SDY376
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
Virginia Pascual
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
Baylor Institute for Immunology Research
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
Systems Biology Approach to Study Influenza Vaccine in Children with Autoimmunity (Juvenile Dermatomyositis JDM) 2013/2014 Cohort (see companion studies SDY369, SDY372, SDY645)
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
Transcriptional profiling of peripheral blood of pediatric patients with juvenile dermatomyositis (JDM) before/after vaccination with seasonal influenza vaccine (Fluzone)
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
This Project will study vaccine responses in sick children. It will address the following questions: 1) which are the best biomarkers of protective immune response to influenza vaccine (in collaboration with Dr. Ramillo’s study for healthy children and here for patients with JDM); 2) how unique autoimmune backgrounds set the stage for responsiveness/unresponsiveness to vaccines; 3) whether vaccination contributes to increase the breadth of autoimmunity in a disease-specific manner. Ultimately, we expect that these studies will shed light on basic aspects of humoral immune responses to vaccines and will permit us to discover biomarkers of response that can be applied to healthy children and to the general population
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
Homo sapiens
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
Subjects with autoimmune disease that are less than or equal to 25 years of age
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
13
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
FCM; DNA microarray; HAI; Virus neutralization
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
Yes
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
Yes (Hai_result)
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
Illumina bead array
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
SDY 369, SDY 372, SDY 645
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
Age
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
Age
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
0, 7, 28, 90
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
Yes (IK_cell_population, IK_cell_population_marker)
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
NA
</td>
</tr>
<tr>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
SDY645
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
Virginia Pascual
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
Baylor Institute for Immunology Research
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
Systems Biology Approach to Study Influenza Vaccine in Children with Autoimmunity (Juvenile Dermatomyositis JDM) 2014/2015 Cohort (see companion studies SDY369, SDY376, SDY372)
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
Transcriptional profiling of peripheral blood of pediatric patients with juvenile dermatomyositis (JDM) before/after vaccination with seasonal influenza vaccine (Fluzone)
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
This Project will study vaccine responses in sick children. It will address the following questions: 1) which are the best biomarkers of protective immune response to influenza vaccine (in collaboration with Dr. Ramillo’s study for healthy children and here for patients with JDM); 2) how unique autoimmune backgrounds set the stage for responsiveness/unresponsiveness to vaccines; 3) whether vaccination contributes to increase the breadth of autoimmunity in a disease-specific manner. Ultimately, we expect that these studies will shed light on basic aspects of humoral immune responses to vaccines and will permit us to discover biomarkers of response that can be applied to healthy children and to the general population
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
Homo sapiens
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
Subjects with autoimmune disease that are less than or equal to 25 years of age
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
11
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
FCM; DNA microarray; HAI; Virus neutralization
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
Yes
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
Yes (Hai_result)
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
Illumina bead array
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
SDY 369, SDY 372, SDY 376
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
Age
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
Age
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
0, 7, 28, 90
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
Yes (IK_cell_population, IK_cell_population_marker)
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
NA
</td>
</tr>
</tbody>
</table>
</div></li>
</ol></li>
</ol></li>
</ol></li>
</ol></li>
</ol></li>
</ol></li>
</ol></li>
</ol></li>
</ol></li>
</ol></li>
</ol></li>
</ol></li>
</ol></li>
</ol>
<p><br />
The table below shows more information for each study, including the meta data available, visit information, sample type, markers in different panels.</p>
<div style="border: 1px solid #ddd; padding: 0px; overflow-y: scroll; height:400px; overflow-x: scroll; width:100%; ">
<table class="table table-striped table-bordered" style="width: auto !important; margin-left: auto; margin-right: auto;">
<thead>
<tr>
<th style="text-align:left;position: sticky; top:0; background-color: #FFFFFF;">
</th>
<th style="text-align:left;position: sticky; top:0; background-color: #FFFFFF;">
Study
</th>
<th style="text-align:left;position: sticky; top:0; background-color: #FFFFFF;">
Cohort
</th>
<th style="text-align:left;position: sticky; top:0; background-color: #FFFFFF;">
Visits.(in.Days)
</th>
<th style="text-align:left;position: sticky; top:0; background-color: #FFFFFF;">
Vaccine
</th>
<th style="text-align:left;position: sticky; top:0; background-color: #FFFFFF;">
Sample.Type
</th>
<th style="text-align:left;position: sticky; top:0; background-color: #FFFFFF;">
Gene.Expression
</th>
<th style="text-align:left;position: sticky; top:0; background-color: #FFFFFF;">
Titer
</th>
<th style="text-align:left;position: sticky; top:0; background-color: #FFFFFF;">
Panels
</th>
<th style="text-align:left;position: sticky; top:0; background-color: #FFFFFF;">
Panels
</th>
<th style="text-align:left;position: sticky; top:0; background-color: #FFFFFF;">
Panels
</th>
<th style="text-align:left;position: sticky; top:0; background-color: #FFFFFF;">
Panels
</th>
<th style="text-align:left;position: sticky; top:0; background-color: #FFFFFF;">
Panels
</th>
<th style="text-align:left;position: sticky; top:0; background-color: #FFFFFF;">
Panels
</th>
<th style="text-align:left;position: sticky; top:0; background-color: #FFFFFF;">
Panels
</th>
<th style="text-align:left;position: sticky; top:0; background-color: #FFFFFF;">
Panels
</th>
<th style="text-align:left;position: sticky; top:0; background-color: #FFFFFF;">
Panels
</th>
<th style="text-align:left;position: sticky; top:0; background-color: #FFFFFF;">
Panels
</th>
<th style="text-align:left;position: sticky; top:0; background-color: #FFFFFF;">
Panels
</th>
<th style="text-align:left;position: sticky; top:0; background-color: #FFFFFF;">
Panels
</th>
<th style="text-align:left;position: sticky; top:0; background-color: #FFFFFF;">
Panels
</th>
<th style="text-align:left;position: sticky; top:0; background-color: #FFFFFF;">
Panels
</th>
<th style="text-align:left;position: sticky; top:0; background-color: #FFFFFF;">
Panels
</th>
<th style="text-align:left;position: sticky; top:0; background-color: #FFFFFF;">
Panels
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
1
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
SDY144
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
Age, Gender, Race
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
Days: 0, 1, 7, 28
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
TIV
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
Whole blood
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
Microarray
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
HAI; NAI
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
Bcell: Markers:- FSC-A,FSC_W,FSC_H,SSC-A,SSC_W,SSC_H,IgD,CD24,CD19,CD20,CD38,CD86,CD45,CD138,CD3CD14,CD27
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
DC
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
Monocyte
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
Tcell: FSC-A,FSC-H,FSC-W,SSC-A,SSC-H,SSC-W,CXCR5,CCR6,CD45RA,CXCR3,CCR7,CD4,CD45,ICOS,CD3,CD8
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
NA
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
NA
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
NA
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
NA
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
NA
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
NA
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
NA
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
NA
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
NA
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
NA
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
NA
</td>
<td style="text-align:left;">
NA
</td>
</tr>
<tr>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
2
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
SDY364
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
Age, Gender, Race
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
Days: 0, 1, 7, 28, 40
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
TIV
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
Whole blood
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
Microarray
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
HAI; NAI
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
Bcell: Markers:- FSC-A,FSC_W,FSC_H,SSC-A,SSC_W,SSC_H,IgD,CD24,CD19,CD20,CD38,CD86,CD45,CD138,CD3CD14,CD27
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
DC
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
Monocyte
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
Tcell: FSC-A,FSC-H,FSC-W,SSC-A,SSC-H,SSC-W,CXCR5,CCR6,CD45RA,CXCR3,CCR7,CD4,CD45,ICOS,CD3,CD8
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
NA
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
NA
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
NA
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
NA
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
NA
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
NA
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
NA
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
NA
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
NA
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
NA
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
NA
</td>
<td style="text-align:left;">
NA
</td>
</tr>
<tr>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
3
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
SDY368
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
Age, Gender, Race
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
Days: 0, 1, 7, 28
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
TIV
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
Whole blood
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
Microarray
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
HAI; NAI
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
Bcell: Markers:- FSC-A,FSC_W,FSC_H,SSC-A,SSC_W,SSC_H,IgD,CD24,CD19,CD20,CD38,CD86,CD45,CD138,CD3CD14,CD27
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
DC
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
Monocyte
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
Tcell: FSC-A,FSC-H,FSC-W,SSC-A,SSC-H,SSC-W,CXCR5,CCR6,CD45RA,CXCR3,CCR7,CD4,CD45,ICOS,CD3,CD8
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
NA
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
NA
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
NA
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
NA
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
NA
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
NA
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
NA
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
NA
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
NA
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
NA
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
NA
</td>
<td style="text-align:left;">
NA
</td>
</tr>
<tr>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
4
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
SDY387
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
Age, Gender, Race
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
Days: 0, 7, 28, 90, 180
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
TIV
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
Whole blood
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
Microarray
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
HAI; NAI
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
Bcell: Markers:- FSC-A,FSC_W,FSC_H,SSC-A,SSC_W,SSC_H,IgD,CD24,CD19,CD20,CD38,CD86,CD45,CD138,CD3CD14,CD27
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
DC
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
Monocyte
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
Tcell: FSC-A,FSC-H,FSC-W,SSC-A,SSC-H,SSC-W,CXCR5,CCR6,CD45RA,CXCR3,CCR7,CD4,CD45,ICOS,CD3,CD8
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
NA
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
NA
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
NA
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
NA
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
NA
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
NA
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
NA
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
NA
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
NA
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
NA
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
NA
</td>
<td style="text-align:left;">
NA
</td>
</tr>
<tr>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
6
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
SDY224
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
Age, Gender, Race
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
0, 1, 2, 3, 4, 5, 6, 7, 8, 9, 10
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
TIV
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
NA
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
RNA-Seq
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
HAI
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
Bcell: Markers:- FSC-A,FSC-H,FSC-W,SSC-A,SSC-H,SSC-W,B7,CCR10,CD19,CD27,CD3,CD38,CD20,LiveDead,CD138,CD62
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
NA
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
NA
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
CD4Tcell: FSC-A,FSC-H,FSC-W,SSC-A,SSC-H,SSC-W,MIP1a,TNFa,IL2,LiveDead,CCL1,CD3,CD45RA,CD8,CD14,Granzymeb,Ki67,CD69,MIP1b,CD4,IFNg
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
NA
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
Innate and Adaptive
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
NA
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
NA
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
NA
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
NA
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
NA
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
NA
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
NA
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
NA
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
NA
</td>
<td style="text-align:left;">
NA
</td>
</tr>
<tr>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
7
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
SDY396
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
Age, Gender, Race
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
0, 1, 2, 3, 4, 5, 6, 7, 8, 9, 10
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
LAIV
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
B-cell and PBMC
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
NA
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
HAI
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
Bcell: Markers:- FSC-A,FSC-H,FSC-W,SSC-A,SSC-H,SSC-W,B7,CCR10,CD19,CD27,CD3,CD38,CD20,LiveDead,CD138,CD62
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
NA
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
NA
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
Tcell:
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
NA
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
Innate and Adaptive
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
NA
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
NA
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
NA
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
NA
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
NA
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
NA
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
NA
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
NA
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
NA
</td>
<td style="text-align:left;">
NA
</td>
</tr>
<tr>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
8
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
SDY564
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
Age, Gender, Race
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
0, 1, 2, 3, 4, 5, 6, 7, 8, 9, 10
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
TIV
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
PBMC
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
NA
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
HAI
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
Bcell: Markers:- FSC-A,FSC-H,FSC-W,SSC-A,SSC-H,SSC-W,B7,CCR10,CD19,CD27,CD3,CD38,CD20,LiveDead,CD138,CD62
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
NA
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
NA
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
CD4Tcell: FSC-A,FSC-H,FSC-W,SSC-A,SSC-H,SSC-W,Ki67,MIP1B,TNFa,CD3,CD45RA,CD8,GzB,IL-2,CD69,CSF,CD4,IFNg
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
NA
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
Innate and Adaptive
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
NA
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
NA
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
NA
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
NA
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
NA
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
NA
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
NA
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
NA
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
NA
</td>
<td style="text-align:left;">
NA
</td>
</tr>
<tr>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
10
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
SDY180
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
Age, Gender, Race
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
7 days before vaccination, 0, 0.5, 1, 3, 7, 10, 28
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
Pneunomax23, Saline
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
NA
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
Microarray
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
HAI; NAI
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
Bcell: Markers:- FSC-A, FSC-H, SSC-A, SSC-H, IgD, CD45, CD138, CD27, CD24, CD19, CD20, CD38
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
DC
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
NA
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
NA
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
NA
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
NA
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
NA
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
NA
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
NA
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
NA
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
NA
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
NA
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
NA
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
NA
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
NA
</td>
<td style="text-align:left;">
NA
</td>
</tr>
<tr>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
12
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
SDY80
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
Age, Gender, Race
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
7 days before vaccination, 0, 1, 7
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
NA
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
PBMC
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
NA
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
NAI
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
Bcell: Markers:- FSC-A, SSC-A, IgA, CD86, CD21, CD38, IgG, CD20, CD23, IgD, IgM, CD10, CD80, Viability, CD27, CD19, CD45
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
Mono_DC: Markers:- FSC-A, SSC-A, IFNa, TNFa, CD40, HLA-DR, CD83, CD11c, Lineage, BDCA-2, CD33, CD86, CD123, Viability, CD4, CD14, CD45
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
NA
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
Tcell: Markers:-FSC-A, SSC-A, CD39, CD38, FOXp3, CD45-RA, CD103, HLA-DR, CD25, CD127, CD197, CD3, CD4, Viability, CD8, CD27, CD45 (Day -7, Day0, Day1, Day7, Day70; 61 subjects)
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
NA
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
NA
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
NA
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
NA
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
NA
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
NA
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
NA
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
NA
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
NA
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
NA
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
NA
</td>
<td style="text-align:left;">
NA
</td>
</tr>
<tr>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
14
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
SDY67
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
Age, Gender, Race
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
0, 3, 28
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
NA
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
PBMC
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
RNA-Seq
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
HAI; NAI
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
Bcell: Markers:- FSC-A, SSC-A, IgD, CD24, CD27, CD3, CD38, CD19, CD20, LEPR
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
NA
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
NA
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
Tcell: Markers:- FSC-A, FSC-H, SSC-A, IL-2, Perforin, CD107a, TNF-a, MIP-1b, IFN-g, CD3, CD8, CD95, CD4
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
Treg: Markers:- FSC-A, SSC-A, CD45RO, CD4, CD38, CD38, CD194, CD127, CD4, CD3, HLA-DR, CD28, CD25 (Day0, Day3, Day28, Day75 available, 149 subjects)
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
Innate: Markers:- FSC-A, SSC-A, CD86, CD20, CD56, CD16, CD123, CD14, CD11C, CD3, HLA DR
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
NA
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
NA
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
NA
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
NA
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
NA
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
NA
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
NA
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
NA
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
NA
</td>
<td style="text-align:left;">
NA
</td>
</tr>
<tr>
<td style="text-align:left;color: black !important;background-color: gray !important;border-left:1px solid;border-right:1px solid;">
16
</td>
<td style="text-align:left;color: black !important;background-color: gray !important;border-left:1px solid;border-right:1px solid;">
SDY212
</td>
<td style="text-align:left;color: black !important;background-color: gray !important;border-left:1px solid;border-right:1px solid;">
NA
</td>
<td style="text-align:left;color: black !important;background-color: gray !important;border-left:1px solid;border-right:1px solid;">
NA
</td>
<td style="text-align:left;color: black !important;background-color: gray !important;border-left:1px solid;border-right:1px solid;">
NA
</td>
<td style="text-align:left;color: black !important;background-color: gray !important;border-left:1px solid;border-right:1px solid;">
NA
</td>
<td style="text-align:left;color: black !important;background-color: gray !important;border-left:1px solid;border-right:1px solid;">
NA
</td>
<td style="text-align:left;color: black !important;background-color: gray !important;border-left:1px solid;border-right:1px solid;">
NA
</td>
<td style="text-align:left;color: black !important;background-color: gray !important;border-left:1px solid;border-right:1px solid;">
Headers unclear
</td>
<td style="text-align:left;color: black !important;background-color: gray !important;border-left:1px solid;border-right:1px solid;">
NA
</td>
<td style="text-align:left;color: black !important;background-color: gray !important;border-left:1px solid;border-right:1px solid;">
NA
</td>
<td style="text-align:left;color: black !important;background-color: gray !important;border-left:1px solid;border-right:1px solid;">
NA
</td>
<td style="text-align:left;color: black !important;background-color: gray !important;border-left:1px solid;border-right:1px solid;">
NA
</td>
<td style="text-align:left;color: black !important;background-color: gray !important;border-left:1px solid;border-right:1px solid;">
NA
</td>
<td style="text-align:left;color: black !important;background-color: gray !important;border-left:1px solid;border-right:1px solid;">
NA
</td>
<td style="text-align:left;color: black !important;background-color: gray !important;border-left:1px solid;border-right:1px solid;">
NA
</td>
<td style="text-align:left;color: black !important;background-color: gray !important;border-left:1px solid;border-right:1px solid;">
NA
</td>
<td style="text-align:left;color: black !important;background-color: gray !important;border-left:1px solid;border-right:1px solid;">
NA
</td>
<td style="text-align:left;color: black !important;background-color: gray !important;border-left:1px solid;border-right:1px solid;">
NA
</td>
<td style="text-align:left;color: black !important;background-color: gray !important;border-left:1px solid;border-right:1px solid;">
NA
</td>
<td style="text-align:left;color: black !important;background-color: gray !important;border-left:1px solid;border-right:1px solid;">
NA
</td>
<td style="text-align:left;color: black !important;background-color: gray !important;border-left:1px solid;border-right:1px solid;">
NA
</td>
<td style="text-align:left;color: black !important;background-color: gray !important;border-left:1px solid;border-right:1px solid;">
NA
</td>
<td style="text-align:left;color: black !important;background-color: gray !important;">
NA
</td>
</tr>
<tr>
<td style="text-align:left;color: black !important;background-color: gray !important;border-left:1px solid;border-right:1px solid;">
18
</td>
<td style="text-align:left;color: black !important;background-color: gray !important;border-left:1px solid;border-right:1px solid;">
SDY38
</td>
<td style="text-align:left;color: black !important;background-color: gray !important;border-left:1px solid;border-right:1px solid;">
Age, Gender, Race
</td>
<td style="text-align:left;color: black !important;background-color: gray !important;border-left:1px solid;border-right:1px solid;">
1
</td>
<td style="text-align:left;color: black !important;background-color: gray !important;border-left:1px solid;border-right:1px solid;">
NA
</td>
<td style="text-align:left;color: black !important;background-color: gray !important;border-left:1px solid;border-right:1px solid;">
PBMC
</td>
<td style="text-align:left;color: black !important;background-color: gray !important;border-left:1px solid;border-right:1px solid;">
NA
</td>
<td style="text-align:left;color: black !important;background-color: gray !important;border-left:1px solid;border-right:1px solid;">
NA
</td>
<td style="text-align:left;color: black !important;background-color: gray !important;border-left:1px solid;border-right:1px solid;">
NA
</td>
<td style="text-align:left;color: black !important;background-color: gray !important;border-left:1px solid;border-right:1px solid;">
NA
</td>
<td style="text-align:left;color: black !important;background-color: gray !important;border-left:1px solid;border-right:1px solid;">
NA
</td>
<td style="text-align:left;color: black !important;background-color: gray !important;border-left:1px solid;border-right:1px solid;">
CD8Tcell: FSC-A, FSC-H, FSC-W, SSC-A, SSC-H, SSC-W, NKP46, TNFA, L/D, CD45RA, CD8, CD14, NKP44, IL2, CD69, CD19, CD4, CD56, IFNG. 12 subjects and 4 time points (48 FCS files)
</td>
<td style="text-align:left;color: black !important;background-color: gray !important;border-left:1px solid;border-right:1px solid;">
NA
</td>
<td style="text-align:left;color: black !important;background-color: gray !important;border-left:1px solid;border-right:1px solid;">
NA
</td>
<td style="text-align:left;color: black !important;background-color: gray !important;border-left:1px solid;border-right:1px solid;">
NA
</td>
<td style="text-align:left;color: black !important;background-color: gray !important;border-left:1px solid;border-right:1px solid;">
NA
</td>
<td style="text-align:left;color: black !important;background-color: gray !important;border-left:1px solid;border-right:1px solid;">
NA
</td>
<td style="text-align:left;color: black !important;background-color: gray !important;border-left:1px solid;border-right:1px solid;">
NA
</td>
<td style="text-align:left;color: black !important;background-color: gray !important;border-left:1px solid;border-right:1px solid;">
NA
</td>
<td style="text-align:left;color: black !important;background-color: gray !important;border-left:1px solid;border-right:1px solid;">
NA
</td>
<td style="text-align:left;color: black !important;background-color: gray !important;border-left:1px solid;border-right:1px solid;">
NA
</td>
<td style="text-align:left;color: black !important;background-color: gray !important;border-left:1px solid;border-right:1px solid;">
NA
</td>
<td style="text-align:left;color: black !important;background-color: gray !important;border-left:1px solid;border-right:1px solid;">
NA
</td>
<td style="text-align:left;color: black !important;background-color: gray !important;">
NA
</td>
</tr>
<tr>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
20
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
SDY241
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
NA
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
NA
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
NA
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
NA
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
NA
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
NA
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
NA
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
NA
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
NA
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
NA
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
NA
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
NA
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
NA
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
NA
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
NA
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
NA
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
NA
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
NA
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
NA
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
NA
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
NA
</td>
<td style="text-align:left;">
NA
</td>
</tr>
<tr>
<td style="text-align:left;color: black !important;background-color: gray !important;border-left:1px solid;border-right:1px solid;">
22
</td>
<td style="text-align:left;color: black !important;background-color: gray !important;border-left:1px solid;border-right:1px solid;">
SDY74
</td>
<td style="text-align:left;color: black !important;background-color: gray !important;border-left:1px solid;border-right:1px solid;">
Age, Gender, Race
</td>
<td style="text-align:left;color: black !important;background-color: gray !important;border-left:1px solid;border-right:1px solid;">
1, 3, 7, 60
</td>
<td style="text-align:left;color: black !important;background-color: gray !important;border-left:1px solid;border-right:1px solid;">
TIV
</td>
<td style="text-align:left;color: black !important;background-color: gray !important;border-left:1px solid;border-right:1px solid;">
Whole Blood
</td>
<td style="text-align:left;color: black !important;background-color: gray !important;border-left:1px solid;border-right:1px solid;">
Microarray
</td>
<td style="text-align:left;color: black !important;background-color: gray !important;border-left:1px solid;border-right:1px solid;">
NA
</td>
<td style="text-align:left;color: black !important;background-color: gray !important;border-left:1px solid;border-right:1px solid;">
Bcell: FSC-A, FSC-H, SSC-A, SSC-H, IgD, CD19, CD38, CD3+8+14+16+56+NKp46, CD27, CD20, CD138
</td>
<td style="text-align:left;color: black !important;background-color: gray !important;border-left:1px solid;border-right:1px solid;">
DC: FSC-A, FSC-H, SSC-A, SSC-H, LIN-1+66b+NKp46+8, BDCA-2, CD2, BDCA-3, CD1c, CD11c, HLA-DR
</td>
<td style="text-align:left;color: black !important;background-color: gray !important;border-left:1px solid;border-right:1px solid;">
Mono: FSC-A, FSC-H, SSC-A, SSC-H, CD16, CD14, CD3+8+19+20+56+NKp46, HLA-DR
</td>
<td style="text-align:left;color: black !important;background-color: gray !important;border-left:1px solid;border-right:1px solid;">
Tcell: FSC-A, FSC-H, SSC-A, SSC-H, CXCR5, CCR6, CXCR3, ICOS, DUMP CD4, CD45RA, CD4
</td>
<td style="text-align:left;color: black !important;background-color: gray !important;border-left:1px solid;border-right:1px solid;">
NA
</td>
<td style="text-align:left;color: black !important;background-color: gray !important;border-left:1px solid;border-right:1px solid;">
NA
</td>
<td style="text-align:left;color: black !important;background-color: gray !important;border-left:1px solid;border-right:1px solid;">
NA
</td>
<td style="text-align:left;color: black !important;background-color: gray !important;border-left:1px solid;border-right:1px solid;">
NA
</td>
<td style="text-align:left;color: black !important;background-color: gray !important;border-left:1px solid;border-right:1px solid;">
NA
</td>
<td style="text-align:left;color: black !important;background-color: gray !important;border-left:1px solid;border-right:1px solid;">
NA
</td>
<td style="text-align:left;color: black !important;background-color: gray !important;border-left:1px solid;border-right:1px solid;">
NA
</td>
<td style="text-align:left;color: black !important;background-color: gray !important;border-left:1px solid;border-right:1px solid;">
NA
</td>
<td style="text-align:left;color: black !important;background-color: gray !important;border-left:1px solid;border-right:1px solid;">
NA
</td>
<td style="text-align:left;color: black !important;background-color: gray !important;border-left:1px solid;border-right:1px solid;">
NA
</td>
<td style="text-align:left;color: black !important;background-color: gray !important;border-left:1px solid;border-right:1px solid;">
NA
</td>
<td style="text-align:left;color: black !important;background-color: gray !important;">
NA
</td>
</tr>
<tr>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
23
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
SDY296
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
Age, Gender, Race
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
7 days before vaccination, 0, 1, 7, 28
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
AIRFV
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
Whole Blood
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
Microarray
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
HAI; NAI
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
Bcell: FSC-A, FSC-H, SSC-A, SSC-H, CD3, CD14, CD19, CD20/CD56, CD38, CD138, CD16, CD27, CD86, CD45
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
DC: FSC-A, FSC-H, SSC-A, SSC-H, LIN-1, BDCA-2, CD2, CD40, CD1c, BDCA-3, HLA-DR, CD11c, CD86, CD45
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
NA
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
Tcell: FSC-A, FSC-H, SSC-A, SSC-H, CXCR5, CCR6, CXCR3, ICOS, CD8, CD3, CD4, HLA-DR, CD45
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
NA
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
NA
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
NA
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
NA
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
NA
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
NA
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
NA
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
NA
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
NA
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
NA
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
NA
</td>
<td style="text-align:left;">
NA
</td>
</tr>
<tr>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
24
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
SDY301
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
Age, Gender, Race
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
0, 1, 7, 28, 120, 240
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
AIRFV
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
Whole Blood
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
Microarray
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
HAI; NAI
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
Bcell: FSC-A, FSC-H, SSC-A, SSC-H, CD3, CD14, CD19, CD20/CD56, CD38, CD138, CD16, CD27, CD86, CD45
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
DC: FSC-A, FSC-H, SSC-A, SSC-H, LIN-1, BDCA-2, CD2, CD40, CD1c, BDCA-3, HLA-DR, CD11c, CD86, CD45
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
NA
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
Tcell: FSC-A, FSC-H, SSC-A, SSC-H, CXCR5, CCR6, CXCR3, ICOS, CD8, CD3, CD4, HLA-DR, CD45
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
NA
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
NA
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
NA
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
NA
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
NA
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
NA
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
NA
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
NA
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
NA
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
NA
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
NA
</td>
<td style="text-align:left;">
NA
</td>
</tr>
<tr>
<td style="text-align:left;color: black !important;background-color: gray !important;border-left:1px solid;border-right:1px solid;">
26
</td>
<td style="text-align:left;color: black !important;background-color: gray !important;border-left:1px solid;border-right:1px solid;">
SDY33
</td>
<td style="text-align:left;color: black !important;background-color: gray !important;border-left:1px solid;border-right:1px solid;">
NA
</td>
<td style="text-align:left;color: black !important;background-color: gray !important;border-left:1px solid;border-right:1px solid;">
NA
</td>
<td style="text-align:left;color: black !important;background-color: gray !important;border-left:1px solid;border-right:1px solid;">
NA
</td>
<td style="text-align:left;color: black !important;background-color: gray !important;border-left:1px solid;border-right:1px solid;">
NA
</td>
<td style="text-align:left;color: black !important;background-color: gray !important;border-left:1px solid;border-right:1px solid;">
NA
</td>
<td style="text-align:left;color: black !important;background-color: gray !important;border-left:1px solid;border-right:1px solid;">
NA
</td>
<td style="text-align:left;color: black !important;background-color: gray !important;border-left:1px solid;border-right:1px solid;">
NA
</td>
<td style="text-align:left;color: black !important;background-color: gray !important;border-left:1px solid;border-right:1px solid;">
NA
</td>
<td style="text-align:left;color: black !important;background-color: gray !important;border-left:1px solid;border-right:1px solid;">
NA
</td>
<td style="text-align:left;color: black !important;background-color: gray !important;border-left:1px solid;border-right:1px solid;">
Tcell: CD45RA, CD28, CD4, CD27, CCR7, CD3, CD8 Tcell: CD45RA, CD38, CD4, HLADR, CCR7, CD3, CD8. (other panels have CD45RA and CCR7)
</td>
<td style="text-align:left;color: black !important;background-color: gray !important;border-left:1px solid;border-right:1px solid;">
Tregs: CD19, FoxP3, CD4, CD25, CD20, CD3, CD27 Tregs: CD19, FoxP3, CD4, CD25, CD20, CD3, CD8
</td>
<td style="text-align:left;color: black !important;background-color: gray !important;border-left:1px solid;border-right:1px solid;">
Adaptive: CD16, CD3, CD45, CD20, CD8, CD4, CD56
</td>
<td style="text-align:left;color: black !important;background-color: gray !important;border-left:1px solid;border-right:1px solid;">
No ab titer/HAI tabels
</td>
<td style="text-align:left;color: black !important;background-color: gray !important;border-left:1px solid;border-right:1px solid;">
NA
</td>
<td style="text-align:left;color: black !important;background-color: gray !important;border-left:1px solid;border-right:1px solid;">
NA
</td>
<td style="text-align:left;color: black !important;background-color: gray !important;border-left:1px solid;border-right:1px solid;">
NA
</td>
<td style="text-align:left;color: black !important;background-color: gray !important;border-left:1px solid;border-right:1px solid;">
NA
</td>
<td style="text-align:left;color: black !important;background-color: gray !important;border-left:1px solid;border-right:1px solid;">
NA
</td>
<td style="text-align:left;color: black !important;background-color: gray !important;border-left:1px solid;border-right:1px solid;">
Tcell: Perforin, Granzyme B, CD27, A2-NLV, CD28, CD3, CD8
</td>
<td style="text-align:left;color: black !important;background-color: gray !important;border-left:1px solid;border-right:1px solid;">
Tcell: Perforin, Granzyme, CD4, CCR7, CD45RA, CD3, CD8
</td>
<td style="text-align:left;color: black !important;background-color: gray !important;border-left:1px solid;border-right:1px solid;">
Tcell: Perforin, GranzymeB, CD8, CD45RA, CCR7, CD3, CD4
</td>
<td style="text-align:left;color: black !important;background-color: gray !important;">
NA
</td>
</tr>
<tr>
<td style="text-align:left;color: black !important;background-color: gray !important;border-left:1px solid;border-right:1px solid;">
28
</td>
<td style="text-align:left;color: black !important;background-color: gray !important;border-left:1px solid;border-right:1px solid;">
SDY314
</td>
<td style="text-align:left;color: black !important;background-color: gray !important;border-left:1px solid;border-right:1px solid;">
NA
</td>
<td style="text-align:left;color: black !important;background-color: gray !important;border-left:1px solid;border-right:1px solid;">
NA
</td>
<td style="text-align:left;color: black !important;background-color: gray !important;border-left:1px solid;border-right:1px solid;">
NA
</td>
<td style="text-align:left;color: black !important;background-color: gray !important;border-left:1px solid;border-right:1px solid;">
NA
</td>
<td style="text-align:left;color: black !important;background-color: gray !important;border-left:1px solid;border-right:1px solid;">
NA
</td>
<td style="text-align:left;color: black !important;background-color: gray !important;border-left:1px solid;border-right:1px solid;">
NA
</td>
<td style="text-align:left;color: black !important;background-color: gray !important;border-left:1px solid;border-right:1px solid;">
Headers unclear
</td>
<td style="text-align:left;color: black !important;background-color: gray !important;border-left:1px solid;border-right:1px solid;">
NA
</td>
<td style="text-align:left;color: black !important;background-color: gray !important;border-left:1px solid;border-right:1px solid;">
NA
</td>
<td style="text-align:left;color: black !important;background-color: gray !important;border-left:1px solid;border-right:1px solid;">
NA
</td>
<td style="text-align:left;color: black !important;background-color: gray !important;border-left:1px solid;border-right:1px solid;">
NA
</td>
<td style="text-align:left;color: black !important;background-color: gray !important;border-left:1px solid;border-right:1px solid;">
NA
</td>
<td style="text-align:left;color: black !important;background-color: gray !important;border-left:1px solid;border-right:1px solid;">
NA
</td>
<td style="text-align:left;color: black !important;background-color: gray !important;border-left:1px solid;border-right:1px solid;">
NA
</td>
<td style="text-align:left;color: black !important;background-color: gray !important;border-left:1px solid;border-right:1px solid;">
NA
</td>
<td style="text-align:left;color: black !important;background-color: gray !important;border-left:1px solid;border-right:1px solid;">
NA
</td>
<td style="text-align:left;color: black !important;background-color: gray !important;border-left:1px solid;border-right:1px solid;">
NA
</td>
<td style="text-align:left;color: black !important;background-color: gray !important;border-left:1px solid;border-right:1px solid;">
NA
</td>
<td style="text-align:left;color: black !important;background-color: gray !important;border-left:1px solid;border-right:1px solid;">
NA
</td>
<td style="text-align:left;color: black !important;background-color: gray !important;border-left:1px solid;border-right:1px solid;">
NA
</td>
<td style="text-align:left;color: black !important;background-color: gray !important;border-left:1px solid;border-right:1px solid;">
NA
</td>
<td style="text-align:left;color: black !important;background-color: gray !important;">
NA
</td>
</tr>
<tr>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
29
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
SDY312
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
Age, Gender, Race (Study compares age groups: A: 18-30; B:60-79; C:80-90)
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
0, 7, 28
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
TIV
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
PBMC
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
Microarray
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
HAI
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
NA
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
NA
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
NA
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
Tcell: FSC-A, FSC-H, FSC-W, SSC-A, SSC-H, SSC-W, CD16/56, CXCR3, CD4, CD33, CD3,CD19, CD8
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
Tregs: FSC-A, FSC-H, FSC-W, SSC-A, SSC-H, SSC-W, CD161, CD25, CD4, CD45RA, CD3, CD127, CD8 (Day 0 and 76 files)
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
NA
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
Nkcell: CD94, CD314, Anti-HLA-DR, CD16, CD3, CD56, CD8
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
Tcell: TCRgd, PD-1, CD4, CD38, CD3, Anti-HLA-DR, CD8
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
Tcell: CD85j, CD28, CD4, CD45RA, CD3, CD27, CD8
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
NA
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
NA
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
NA
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
NA
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
NA
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
NA
</td>
<td style="text-align:left;">
NA
</td>
</tr>
<tr>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
30
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
SDY311
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
Age, Gender, Race (Study compares age groups: A: 18-30; B:60-79; C:80-90)
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
0, 7, 28
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
TIV
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
PBMC
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
Microarray
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
HAI
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
NA
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
NA
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
NA
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
Tcell: FSC-A, FSC-H, FSC-W, SSC-A, SSC-H, SSC-W, pSTAT1, pSTAT5, CD4/CD20, CD33, CD3, CD45RA, pSTAT3
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
NA
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
NA
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
NA
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
NA
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
NA
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
NA
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
NA
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
NA
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
NA
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
NA
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
NA
</td>
<td style="text-align:left;">
NA
</td>
</tr>
<tr>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
31
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
SDY112
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
Age, Gender, Race
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
0, 7, 28
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
TIV
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
PBMC
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
.CEL
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
HAI
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
NA
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
NA
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
NA
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
Tcell: FSC-A, FSC-H, FSC-W, SSC-A, SSC-H, SSC-W, pSTAT1, pSTAT5, CD4/CD20, CD33, CD3, CD45RA, pSTAT3
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
NA
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
NA
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
NA
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
NA
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
NA
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
NA
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
NA
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
NA
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
NA
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
NA
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
NA
</td>
<td style="text-align:left;">
NA
</td>
</tr>
<tr>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
32
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
SDY315
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
Age, Gender, Race (Study compares age groups: A: 18-30; B:60-79; C:80-90)
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
0, 28
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
TIV
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
PBMC, Whole Blood
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
.CEL
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
HAI
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
NA
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
NA
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
NA
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
Tcell: FSC-A, FSC-H, FSC-W, SSC-A, SSC-H, SSC-W, pSTAT1, pSTAT5, CD4/CD20, CD33, CD3, CD45RA, pSTAT3
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
NA
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
NA
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
NA
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
NA
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
NA
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
NA
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
NA
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
NA
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
NA
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
NA
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
NA
</td>
<td style="text-align:left;">
NA
</td>
</tr>
<tr>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
34
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
SDY514
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
Age
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
0, 9, 28
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
NA
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
PBMC
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
NA
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
HAI
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
Bcell: FSC-A, FSC-H, FSC-W, SSC-A, SSC-H, SSC-W, IgD, CD24, CD19, CD38, CD3, CD27, CD20
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
NA
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
NA
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
Tcell: FSC-A, FSC-H, FSC-W, SSC-A, SSC-H, SSC-W, pSTAT-1, pSTAT-5, CD20/CD4, CD33, CD3, CD45RA,pSTAT-3
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
Tregs: FSC-A, FSC-H, FSC-W, SSC-A, SSC-H, SSC-W, CD161, CD25, CD4, CD45RA, CD3, CD127, CD8 (only one visit, i.e. Day 0 and 73 files)
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
NA
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
Nkcell: FSC-A, FSC-H, FSC-W, SSC-A, SSC-H, SSC-W, CD94, CD314, Anti-HLA-DR, CD16, CD3, CD56, CD8
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
Tcell: FSC-A, FSC-H, FSC-W, SSC-A, SSC-H, SSC-W, TCRgd, PD-1, CD4, CD38, CD3, Anti-HLA-DR, CD8
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
Tcell: CD85j, CD28, CD4, CD45RA, CD3, CD27, CD8
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
Tcell: CD16/CD56, CXCR3, CD4, CD33, CD3, CD19, CD8
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
NA
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
NA
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
NA
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
NA
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
NA
</td>
<td style="text-align:left;">
NA
</td>
</tr>
<tr>
<td style="text-align:left;color: black !important;background-color: gray !important;border-left:1px solid;border-right:1px solid;">
36
</td>
<td style="text-align:left;color: black !important;background-color: gray !important;border-left:1px solid;border-right:1px solid;">
SDY515
</td>
<td style="text-align:left;color: black !important;background-color: gray !important;border-left:1px solid;border-right:1px solid;">
NA
</td>
<td style="text-align:left;color: black !important;background-color: gray !important;border-left:1px solid;border-right:1px solid;">
NA
</td>
<td style="text-align:left;color: black !important;background-color: gray !important;border-left:1px solid;border-right:1px solid;">
NA
</td>
<td style="text-align:left;color: black !important;background-color: gray !important;border-left:1px solid;border-right:1px solid;">
NA
</td>
<td style="text-align:left;color: black !important;background-color: gray !important;border-left:1px solid;border-right:1px solid;">
NA
</td>
<td style="text-align:left;color: black !important;background-color: gray !important;border-left:1px solid;border-right:1px solid;">
NA
</td>
<td style="text-align:left;color: black !important;background-color: gray !important;border-left:1px solid;border-right:1px solid;">
50 files only
</td>
<td style="text-align:left;color: black !important;background-color: gray !important;border-left:1px solid;border-right:1px solid;">
NA
</td>
<td style="text-align:left;color: black !important;background-color: gray !important;border-left:1px solid;border-right:1px solid;">
NA
</td>
<td style="text-align:left;color: black !important;background-color: gray !important;border-left:1px solid;border-right:1px solid;">
NA
</td>
<td style="text-align:left;color: black !important;background-color: gray !important;border-left:1px solid;border-right:1px solid;">
NA
</td>
<td style="text-align:left;color: black !important;background-color: gray !important;border-left:1px solid;border-right:1px solid;">
NA
</td>
<td style="text-align:left;color: black !important;background-color: gray !important;border-left:1px solid;border-right:1px solid;">
NA
</td>
<td style="text-align:left;color: black !important;background-color: gray !important;border-left:1px solid;border-right:1px solid;">
NA
</td>
<td style="text-align:left;color: black !important;background-color: gray !important;border-left:1px solid;border-right:1px solid;">
NA
</td>
<td style="text-align:left;color: black !important;background-color: gray !important;border-left:1px solid;border-right:1px solid;">
NA
</td>
<td style="text-align:left;color: black !important;background-color: gray !important;border-left:1px solid;border-right:1px solid;">
NA
</td>
<td style="text-align:left;color: black !important;background-color: gray !important;border-left:1px solid;border-right:1px solid;">
NA
</td>
<td style="text-align:left;color: black !important;background-color: gray !important;border-left:1px solid;border-right:1px solid;">
NA
</td>
<td style="text-align:left;color: black !important;background-color: gray !important;border-left:1px solid;border-right:1px solid;">
NA
</td>
<td style="text-align:left;color: black !important;background-color: gray !important;border-left:1px solid;border-right:1px solid;">
NA
</td>
<td style="text-align:left;color: black !important;background-color: gray !important;">
NA
</td>
</tr>
<tr>
<td style="text-align:left;color: black !important;background-color: gray !important;border-left:1px solid;border-right:1px solid;">
38
</td>
<td style="text-align:left;color: black !important;background-color: gray !important;border-left:1px solid;border-right:1px solid;">
SDY519
</td>
<td style="text-align:left;color: black !important;background-color: gray !important;border-left:1px solid;border-right:1px solid;">
NA
</td>
<td style="text-align:left;color: black !important;background-color: gray !important;border-left:1px solid;border-right:1px solid;">
NA
</td>
<td style="text-align:left;color: black !important;background-color: gray !important;border-left:1px solid;border-right:1px solid;">
NA
</td>
<td style="text-align:left;color: black !important;background-color: gray !important;border-left:1px solid;border-right:1px solid;">
NA
</td>
<td style="text-align:left;color: black !important;background-color: gray !important;border-left:1px solid;border-right:1px solid;">
NA
</td>
<td style="text-align:left;color: black !important;background-color: gray !important;border-left:1px solid;border-right:1px solid;">
NA
</td>
<td style="text-align:left;color: black !important;background-color: gray !important;border-left:1px solid;border-right:1px solid;">
54 files only
</td>
<td style="text-align:left;color: black !important;background-color: gray !important;border-left:1px solid;border-right:1px solid;">
NA
</td>
<td style="text-align:left;color: black !important;background-color: gray !important;border-left:1px solid;border-right:1px solid;">
NA
</td>
<td style="text-align:left;color: black !important;background-color: gray !important;border-left:1px solid;border-right:1px solid;">
NA
</td>
<td style="text-align:left;color: black !important;background-color: gray !important;border-left:1px solid;border-right:1px solid;">
NA
</td>
<td style="text-align:left;color: black !important;background-color: gray !important;border-left:1px solid;border-right:1px solid;">
NA
</td>
<td style="text-align:left;color: black !important;background-color: gray !important;border-left:1px solid;border-right:1px solid;">
NA
</td>
<td style="text-align:left;color: black !important;background-color: gray !important;border-left:1px solid;border-right:1px solid;">
NA
</td>
<td style="text-align:left;color: black !important;background-color: gray !important;border-left:1px solid;border-right:1px solid;">
NA
</td>
<td style="text-align:left;color: black !important;background-color: gray !important;border-left:1px solid;border-right:1px solid;">
NA
</td>
<td style="text-align:left;color: black !important;background-color: gray !important;border-left:1px solid;border-right:1px solid;">
NA
</td>
<td style="text-align:left;color: black !important;background-color: gray !important;border-left:1px solid;border-right:1px solid;">
NA
</td>
<td style="text-align:left;color: black !important;background-color: gray !important;border-left:1px solid;border-right:1px solid;">
NA
</td>
<td style="text-align:left;color: black !important;background-color: gray !important;border-left:1px solid;border-right:1px solid;">
NA
</td>
<td style="text-align:left;color: black !important;background-color: gray !important;border-left:1px solid;border-right:1px solid;">
NA
</td>
<td style="text-align:left;color: black !important;background-color: gray !important;">
NA
</td>
</tr>
<tr>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
40
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
SDY113
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
Age, Gender, Race (Study compares age groups: A: 18-30; B:60-79; C:80-90)
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
0, 7, 28
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
TIV/LAIV
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
PBMC
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
NA
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
HAI
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
NA
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
NA
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
NA
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
Tcell: FSC-A, FSC-H, FSC-W, SSC-A, SSC-H, SSC-W, pSTAT1, pSTAT5, CD4/CD20, CD33, CD3, CD45RA, pSTAT3
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
NA
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
NA
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
NA
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
NA
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
NA
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
NA
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
NA
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
NA
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
NA
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
NA
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
NA
</td>
<td style="text-align:left;">
NA
</td>
</tr>
<tr>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
42
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
SDY305
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
Age, Gender, Race
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
0, 7, 28
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
TIV
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
Whole Blood, PBMC
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
.CEL files
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
HAI
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
Bcell: FSC-A, FSC-W, SSC-A, IgA, Ac1, CD49f, CD38, CCR10, CD4, CLA, CD45RA, P-sel_Ig, CD19, CD62L
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
NA
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
NA
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
Tcell: FSC-A, FSC-H, FSC-W, SSC-A, SSC-H, SSC-W, pSTAT1, pSTAT5, CD4/CD20, CD33, CD3, CD45RA, pSTAT3
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
NA
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
NA
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
NA
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
NA
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
NA
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
NA
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
NA
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
NA
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
NA
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
NA
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
NA
</td>
<td style="text-align:left;">
NA
</td>
</tr>
<tr>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
44
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
SDY202
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
Age, Gender, Race
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
0, 7, 14, 28
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
Monovalent
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
Whole Blood, PBMC, Bcell
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
NA
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
HAI
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
Bcell: FSC-A, FSC-H, FSC-W, SSC-A, SSC-H, SSC-W, IgD, CD24, CD19, CD38, CD3, CD27, CD20
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
NA
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
NA
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
Tcell: FSC-A, FSC-H, FSC-W, SSC-A, SSC-H, SSC-W, pSTAT1, pSTAT5, CD20/CD4, CD33, CD3, CD45RA, pSTAT3
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
Tregs: FSC-A, FSC-H, FSC-W, SSC-A, SSC-H, SSC-W, CD161, CD25, CD4, CD45RA, CD3, CD127, CD8 (Day 0; 78 files)
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
NA
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
Nkcell: FSC-A, FSC-H, FSC-W, SSC-A, SSC-H, SSC-W, CD94, CD314, Anti-HLA-DR, CD16, CD3, CD8
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
Tcell: FSC-A, FSC-H, FSC-W, SSC-A, SSC-H, SSC-W, TCRgd, PD-1, CD4, CD38, CD3, Anti-HLA-DR, CD8
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
Tcell: FSC-A, FSC-H, FSC-W, SSC-A, SSC-H, SSC-W, CD85j, CD28, CD4, CD45RA, CD3, CD27, CD8
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
Tcell: CD16/CD56, CXCR3, CD4, CD33, CD3, CD19, CD8
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
NA
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
NA
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
NA
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
NA
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
NA
</td>
<td style="text-align:left;">
NA
</td>
</tr>
<tr>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
46
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
SDY583
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
Age
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
1, 2, 3, 4, 5, 6, 7, 8, 9, 20
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
TIV
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
Total cells, Bcell
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
NA
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
NA
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
Bcell: FSC-A, FSC-H, FSC-W, SSC-A, SSC-H, SSC-W, CD95, CD3, CD19, PNA, CD93, Ki67, L/D, IgM, CD138, IgD, B220, CD69
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
NA
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
NA
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
NA
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
NA
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
NA
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
NA
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
NA
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
NA
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
NA
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
NA
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
NA
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
NA
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
NA
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
NA
</td>
<td style="text-align:left;">
NA
</td>
</tr>
<tr>
<td style="text-align:left;color: black !important;background-color: gray !important;border-left:1px solid;border-right:1px solid;">
48
</td>
<td style="text-align:left;color: black !important;background-color: gray !important;border-left:1px solid;border-right:1px solid;">
SDY585
</td>
<td style="text-align:left;color: black !important;background-color: gray !important;border-left:1px solid;border-right:1px solid;">
Age
</td>
<td style="text-align:left;color: black !important;background-color: gray !important;border-left:1px solid;border-right:1px solid;">
NA
</td>
<td style="text-align:left;color: black !important;background-color: gray !important;border-left:1px solid;border-right:1px solid;">
Influenza vaccine coupled with adjuvant in murine model
</td>
<td style="text-align:left;color: black !important;background-color: gray !important;border-left:1px solid;border-right:1px solid;">
NA
</td>
<td style="text-align:left;color: black !important;background-color: gray !important;border-left:1px solid;border-right:1px solid;">
NA
</td>
<td style="text-align:left;color: black !important;background-color: gray !important;border-left:1px solid;border-right:1px solid;">
NA
</td>
<td style="text-align:left;color: black !important;background-color: gray !important;border-left:1px solid;border-right:1px solid;">
Bcell: IgD, Ki67, Dump, PNA, CD93, CD95, L/D, CD138, IgM, CD19, IgG, IgA, CD45R, CD69
</td>
<td style="text-align:left;color: black !important;background-color: gray !important;border-left:1px solid;border-right:1px solid;">
NA
</td>
<td style="text-align:left;color: black !important;background-color: gray !important;border-left:1px solid;border-right:1px solid;">
NA
</td>
<td style="text-align:left;color: black !important;background-color: gray !important;border-left:1px solid;border-right:1px solid;">
Tcell: Ly6c, MHCII, CD11b, CD70, CD103, L/D, CD86, CD8a, CD11c, CD4, Clec9A, CD40, SiglecH
</td>
<td style="text-align:left;color: black !important;background-color: gray !important;border-left:1px solid;border-right:1px solid;">
NA
</td>
<td style="text-align:left;color: black !important;background-color: gray !important;border-left:1px solid;border-right:1px solid;">
NA
</td>
<td style="text-align:left;color: black !important;background-color: gray !important;border-left:1px solid;border-right:1px solid;">
NA
</td>
<td style="text-align:left;color: black !important;background-color: gray !important;border-left:1px solid;border-right:1px solid;">
NA
</td>
<td style="text-align:left;color: black !important;background-color: gray !important;border-left:1px solid;border-right:1px solid;">
NA
</td>
<td style="text-align:left;color: black !important;background-color: gray !important;border-left:1px solid;border-right:1px solid;">
NA
</td>
<td style="text-align:left;color: black !important;background-color: gray !important;border-left:1px solid;border-right:1px solid;">
NA
</td>
<td style="text-align:left;color: black !important;background-color: gray !important;border-left:1px solid;border-right:1px solid;">
NA
</td>
<td style="text-align:left;color: black !important;background-color: gray !important;border-left:1px solid;border-right:1px solid;">
NA
</td>
<td style="text-align:left;color: black !important;background-color: gray !important;border-left:1px solid;border-right:1px solid;">
NA
</td>
<td style="text-align:left;color: black !important;background-color: gray !important;border-left:1px solid;border-right:1px solid;">
NA
</td>
<td style="text-align:left;color: black !important;background-color: gray !important;">
NA
</td>
</tr>
<tr>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
50
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
SDY56
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
Age, Gender, Race
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
0, 3, 7, 14, 30
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
TIV
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
PBMC, Whole blood
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
.CEL files
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
HAI
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
Bcell: FSC-H, SSC-H, CD19, CD38, CD3/CD20, CD27
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
DC: FSC-A, FSC-H, FSC-W, SSC-A, SSC-H, SSC-W, CD86, CD11c, HLA-DR, Lin, BDCA1, CD11b, A430, CCR7, CD123
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
NA
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
NA
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
NA
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
Adaptive: FSC-A, FSC-H, FSC-W, SSC-A, SSC-H, SSC-W, CD19, CD16, CD4, CD69, CD56, CCR5, A430, CD3, CD86, HLA-DR, CD14
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
NA
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
NA
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
NA
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
NA
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
NA
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
NA
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
NA
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
NA
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
NA
</td>
<td style="text-align:left;">
NA
</td>
</tr>
<tr>
<td style="text-align:left;color: black !important;background-color: gray !important;border-left:1px solid;border-right:1px solid;">
52
</td>
<td style="text-align:left;color: black !important;background-color: gray !important;border-left:1px solid;border-right:1px solid;">
SDY269
</td>
<td style="text-align:left;color: black !important;background-color: gray !important;border-left:1px solid;border-right:1px solid;">
NA
</td>
<td style="text-align:left;color: black !important;background-color: gray !important;border-left:1px solid;border-right:1px solid;">
NA
</td>
<td style="text-align:left;color: black !important;background-color: gray !important;border-left:1px solid;border-right:1px solid;">
NA
</td>
<td style="text-align:left;color: black !important;background-color: gray !important;border-left:1px solid;border-right:1px solid;">
NA
</td>
<td style="text-align:left;color: black !important;background-color: gray !important;border-left:1px solid;border-right:1px solid;">
NA
</td>
<td style="text-align:left;color: black !important;background-color: gray !important;border-left:1px solid;border-right:1px solid;">
NA
</td>
<td style="text-align:left;color: black !important;background-color: gray !important;border-left:1px solid;border-right:1px solid;">
Bcell: FSC-H, SSC-H, CD19, CD38, CD3/CD20, CD27 (only Day7 data available for FCM)
</td>
<td style="text-align:left;color: black !important;background-color: gray !important;border-left:1px solid;border-right:1px solid;">
NA
</td>
<td style="text-align:left;color: black !important;background-color: gray !important;border-left:1px solid;border-right:1px solid;">
NA
</td>
<td style="text-align:left;color: black !important;background-color: gray !important;border-left:1px solid;border-right:1px solid;">
NA
</td>
<td style="text-align:left;color: black !important;background-color: gray !important;border-left:1px solid;border-right:1px solid;">
NA
</td>
<td style="text-align:left;color: black !important;background-color: gray !important;border-left:1px solid;border-right:1px solid;">
NA
</td>
<td style="text-align:left;color: black !important;background-color: gray !important;border-left:1px solid;border-right:1px solid;">
NA
</td>
<td style="text-align:left;color: black !important;background-color: gray !important;border-left:1px solid;border-right:1px solid;">
NA
</td>
<td style="text-align:left;color: black !important;background-color: gray !important;border-left:1px solid;border-right:1px solid;">
NA
</td>
<td style="text-align:left;color: black !important;background-color: gray !important;border-left:1px solid;border-right:1px solid;">
NA
</td>
<td style="text-align:left;color: black !important;background-color: gray !important;border-left:1px solid;border-right:1px solid;">
NA
</td>
<td style="text-align:left;color: black !important;background-color: gray !important;border-left:1px solid;border-right:1px solid;">
NA
</td>
<td style="text-align:left;color: black !important;background-color: gray !important;border-left:1px solid;border-right:1px solid;">
NA
</td>
<td style="text-align:left;color: black !important;background-color: gray !important;border-left:1px solid;border-right:1px solid;">
NA
</td>
<td style="text-align:left;color: black !important;background-color: gray !important;border-left:1px solid;border-right:1px solid;">
NA
</td>
<td style="text-align:left;color: black !important;background-color: gray !important;">
NA
</td>
</tr>
<tr>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
54
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
SDY404
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
Age, Gender, Race
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
0, 2, 7, 24, 28, 32
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
NA
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
PBMC, Whole Blood
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
NA
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
HAI; NAI
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
Bcell: FSC-A, FSC-H, FSc-W, SSC-A, SSC-H, SSC-W, CD3, IgD, CD38, CD10, CD20, CD24, Viability, CD27, CD21, CD19
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
DC: FSC-A, FSC-H, FSC-W, SSC-A, SSC-H, SSC-H, CD14, HLA-DR, CD16, CD3CD19CD20, CD56, Viability, CD11c, HLA-A2, CD123
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
NA
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
NA
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
Tregs: FSC-A, FSC-H, FSC-W, SSC-A, SSC-H, SSC-W, CD3, HLA-DR, CD127, FoxP3, CD45RO, CD25, Viability, CCR4, CD39, CD4 (Day0, 2, 3, 4, 7, 11, 28, 35 and 53 subjects)
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
NA
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
NA
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
NA
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
NA
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
NA
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
Tcell: CD3, CD4, PD-1, CD45RO, CD8, CXCR3, Viability, CCR6, CCR4
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
Tcell: IL-17, CD3, CD16, IFNg, CD8, TNFa, Viability, CD56, Granzyme B, CD4
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
Tcell: CD3, HLA-DR, T-Bet, CCR7, CD8, EOMES, Viability, CD45RA, Ki67, CD4
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
Tcell: CD3, HLA-DR, iNKT, CD27, CD8, 2B4, Viability, CD56, CD16, CD4
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
Tcell: CD3, HLA-DR, CD38, CD28, CD8, CCR7, Viability, CD45RA, CD27, CD4
</td>
<td style="text-align:left;">
Tcell: CD3, HLA-DR, CD38, CD27, CD8, CD57, Viability, PD-1, CD127, CD4
</td>
</tr>
<tr>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
56
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
SDY272
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
Age
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
0, 7, 10, 14, 28, 60
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
NA
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
PBMC
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
NA
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
NAI
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
Bcell: FSC-A, FSC-H, FSC-W, SSC-A, SSC-H, SSC-W, CD27, CD38, CD3/CD14, LD, CD19, CD20
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
NA
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
NA
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
Tcell: FSC-A, FSC-H, SSC-A, SSC-W, CD160, CD27, IL-2, Dead, CD57, CD3, Cd45RA, CD8, Lag3, IFNg, CD14-16-19, PD-1, 2B4, CD4, TNFa
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
NA
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
NA
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
NA
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
NA
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
NA
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
NA
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
NA
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
NA
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
NA
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
NA
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
NA
</td>
<td style="text-align:left;">
NA
</td>
</tr>
<tr>
<td style="text-align:left;color: black !important;background-color: gray !important;border-left:1px solid;border-right:1px solid;">
57
</td>
<td style="text-align:left;color: black !important;background-color: gray !important;border-left:1px solid;border-right:1px solid;">
SDY622
</td>
<td style="text-align:left;color: black !important;background-color: gray !important;border-left:1px solid;border-right:1px solid;">
NA
</td>
<td style="text-align:left;color: black !important;background-color: gray !important;border-left:1px solid;border-right:1px solid;">
NA
</td>
<td style="text-align:left;color: black !important;background-color: gray !important;border-left:1px solid;border-right:1px solid;">
NA
</td>
<td style="text-align:left;color: black !important;background-color: gray !important;border-left:1px solid;border-right:1px solid;">
NA
</td>
<td style="text-align:left;color: black !important;background-color: gray !important;border-left:1px solid;border-right:1px solid;">
NA
</td>
<td style="text-align:left;color: black !important;background-color: gray !important;border-left:1px solid;border-right:1px solid;">
NA
</td>
<td style="text-align:left;color: black !important;background-color: gray !important;border-left:1px solid;border-right:1px solid;">
R couldn’t read the files should analyze them later
</td>
<td style="text-align:left;color: black !important;background-color: gray !important;border-left:1px solid;border-right:1px solid;">
NA
</td>
<td style="text-align:left;color: black !important;background-color: gray !important;border-left:1px solid;border-right:1px solid;">
NA
</td>
<td style="text-align:left;color: black !important;background-color: gray !important;border-left:1px solid;border-right:1px solid;">
NA
</td>
<td style="text-align:left;color: black !important;background-color: gray !important;border-left:1px solid;border-right:1px solid;">
NA
</td>
<td style="text-align:left;color: black !important;background-color: gray !important;border-left:1px solid;border-right:1px solid;">
NA
</td>
<td style="text-align:left;color: black !important;background-color: gray !important;border-left:1px solid;border-right:1px solid;">
NA
</td>
<td style="text-align:left;color: black !important;background-color: gray !important;border-left:1px solid;border-right:1px solid;">
NA
</td>
<td style="text-align:left;color: black !important;background-color: gray !important;border-left:1px solid;border-right:1px solid;">
NA
</td>
<td style="text-align:left;color: black !important;background-color: gray !important;border-left:1px solid;border-right:1px solid;">
NA
</td>
<td style="text-align:left;color: black !important;background-color: gray !important;border-left:1px solid;border-right:1px solid;">
NA
</td>
<td style="text-align:left;color: black !important;background-color: gray !important;border-left:1px solid;border-right:1px solid;">
NA
</td>
<td style="text-align:left;color: black !important;background-color: gray !important;border-left:1px solid;border-right:1px solid;">
NA
</td>
<td style="text-align:left;color: black !important;background-color: gray !important;border-left:1px solid;border-right:1px solid;">
NA
</td>
<td style="text-align:left;color: black !important;background-color: gray !important;border-left:1px solid;border-right:1px solid;">
NA
</td>
<td style="text-align:left;color: black !important;background-color: gray !important;">
NA
</td>
</tr>
<tr>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
58
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
SDY648
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
Age, Gender, Race
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
0, 7, 28
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
TIV
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
PBMC
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
Microarray
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
NAI
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
Bcell1: CD3CD14, CD19, CD20, CD27, CD38, IgA, IgG, IgD, LD, FcRL4, PD-L2. Bcell2: CD3CD14, CD19, CD20, CD27, CD38, Glut-1, IgD, LD, FcRL4, PD-L1
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
NA
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
NA
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
Tcell: IL-2, LiveDead, CD3, CD45RA, CD8, PD-1, CD27, CXCR5, IFNg, CXCR3, Ki-67, CD200, CD38, ICOS, CD4, TNFa
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
NA
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
NA
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
NA
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
NA
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
NA
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
NA
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
NA
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
NA
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
Tcell: FoxP3, CD141619dead, CD57, CD3, CD45RA, CD8, PD1, CD27, CXCR5, Ki67, CXCR3, Tbet, Eomes, CD38, P16INKa, CD4
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
NA
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
NA
</td>
<td style="text-align:left;">
Tcell: CD1416dead, CD57, CD3, CD45RA, CD8, PD1, CD27, CXCR5, Ki67, CXCR3, SirT1, Bim, CD38, CD71, CD4, ICOS
</td>
</tr>
<tr>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
59
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
SDY739
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
Age
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
0, 7, 28
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
NA
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
PBMC
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
Microarray
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
NAI
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
Bcell: FSC-A, FSC-H, FSC-W, SSC-A, SSC-H, SSC-W, FoxP3, CD38, CD3/CD4, L/D, CD20, PD-1, CD19, CD27, IgG, ICOS, ligand, IgD, IgM
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
NA
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
NA
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
Tcell: FSC-A, FSC-H, FSC-W, SSC-A, SSC-H, SSC-W, PD1, CXCR5, CD8, CD3, CD45RA, CD4, CD27, CD38, HEYL, Ki67, CD14-16-19dead, Foxp1, Itch, PPARg, STK39, Foxo1, ICOS
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
Tregs: FSC-A, FSC-H, FSC-W, SSC-A, SSC-H, SSC-W, PD1, CXCR5, CD8, CD3, CD45RA, CD25, CD27, CTLA4, Helios, Ki67, CD14-16-19dead, CD38, CD39, Foxp3, ICOS, CD4, CD127 (Day 0, 63 subjects)
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
NA
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
NA
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
NA
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
NA
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
NA
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
Tcell: PD1, CXCR5, CD8, CD3, CD45RA, CD4, CD27, CD38, p21, Ki67, CD14-16-19dead, gH2AX, p16, CD28, SirT2, ICOS
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
NA
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
NA
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
NA
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
NA
</td>
<td style="text-align:left;">
NA
</td>
</tr>
<tr>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
60
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
SDY819
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
Age
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
0, 7, 28
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
NA
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
PBMC
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
NA
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
NAI
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
Bcell: FSC-A, FSC-H, FSC-W, SSC-A, SSC-H, SSC-W, pAKT, IgD, CD3CD14, LD, CD20, IgG, CD19, CD38, CD27, Sirt-1, IgM, Oct-2, Bcl-6, CD138
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
NA
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
NA
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
NA
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
NA
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
NA
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
NA
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
NA
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
NA
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
NA
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
NA
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
NA
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
NA
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
NA
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
NA
</td>
<td style="text-align:left;">
NA
</td>
</tr>
<tr>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
62
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
SDY522
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
Age
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
0, 1, 7, 28, 30
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
NA
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
PBMC
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
Microarray
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
HAI; NAI
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
Bcell: FSC-A, FSC-H, FSC-W, SSC-A, SSC-H, SSC-W, IgD, CD24, CD19, CD20, CD38, CD86, CD45, CD138, CD3/CD14, CD27
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
NA
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
NA
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
NA
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
NA
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
NA
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
NA
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
NA
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
NA
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
NA
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
NA
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
NA
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
NA
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
NA
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
NA
</td>
<td style="text-align:left;">
NA
</td>
</tr>
<tr>
<td style="text-align:left;color: black !important;background-color: gray !important;border-left:1px solid;border-right:1px solid;">
64
</td>
<td style="text-align:left;color: black !important;background-color: gray !important;border-left:1px solid;border-right:1px solid;">
SDY34
</td>
<td style="text-align:left;color: black !important;background-color: gray !important;border-left:1px solid;border-right:1px solid;">
Age, Gender, Race
</td>
<td style="text-align:left;color: black !important;background-color: gray !important;border-left:1px solid;border-right:1px solid;">
0, 1, 7, 28 , 30
</td>
<td style="text-align:left;color: black !important;background-color: gray !important;border-left:1px solid;border-right:1px solid;">
NA
</td>
<td style="text-align:left;color: black !important;background-color: gray !important;border-left:1px solid;border-right:1px solid;">
Whole Blood
</td>
<td style="text-align:left;color: black !important;background-color: gray !important;border-left:1px solid;border-right:1px solid;">
.CEL files
</td>
<td style="text-align:left;color: black !important;background-color: gray !important;border-left:1px solid;border-right:1px solid;">
NA
</td>
<td style="text-align:left;color: black !important;background-color: gray !important;border-left:1px solid;border-right:1px solid;">
Bcell: CD19, CD38, CD3/CD20, CD27
</td>
<td style="text-align:left;color: black !important;background-color: gray !important;border-left:1px solid;border-right:1px solid;">
NA
</td>
<td style="text-align:left;color: black !important;background-color: gray !important;border-left:1px solid;border-right:1px solid;">
NA
</td>
<td style="text-align:left;color: black !important;background-color: gray !important;border-left:1px solid;border-right:1px solid;">
Tcell: CD3, CD45
</td>
<td style="text-align:left;color: black !important;background-color: gray !important;border-left:1px solid;border-right:1px solid;">
NA
</td>
<td style="text-align:left;color: black !important;background-color: gray !important;border-left:1px solid;border-right:1px solid;">
NA
</td>
<td style="text-align:left;color: black !important;background-color: gray !important;border-left:1px solid;border-right:1px solid;">
NA
</td>
<td style="text-align:left;color: black !important;background-color: gray !important;border-left:1px solid;border-right:1px solid;">
NA
</td>
<td style="text-align:left;color: black !important;background-color: gray !important;border-left:1px solid;border-right:1px solid;">
NA
</td>
<td style="text-align:left;color: black !important;background-color: gray !important;border-left:1px solid;border-right:1px solid;">
NA
</td>
<td style="text-align:left;color: black !important;background-color: gray !important;border-left:1px solid;border-right:1px solid;">
NA
</td>
<td style="text-align:left;color: black !important;background-color: gray !important;border-left:1px solid;border-right:1px solid;">
NA
</td>
<td style="text-align:left;color: black !important;background-color: gray !important;border-left:1px solid;border-right:1px solid;">
NA
</td>
<td style="text-align:left;color: black !important;background-color: gray !important;border-left:1px solid;border-right:1px solid;">
NA
</td>
<td style="text-align:left;color: black !important;background-color: gray !important;border-left:1px solid;border-right:1px solid;">
NA
</td>
<td style="text-align:left;color: black !important;background-color: gray !important;">
NA
</td>
</tr>
<tr>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
66
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
SDY167
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
Age, Gender, Race
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
14 days before vaccination, 0, 14, 28, 30, 42, 67, 70, 182, 283, 294, 302
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
NA
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
Whole Blood
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
NA
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
HAI
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
NA
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
NA
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
NA
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
Tcell: FSC-A, FSC-H, SSC-A, CD8, IL2/IFN, CD4, CD3
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
NA
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
NA
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
NA
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
NA
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
NA
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
NA
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
NA
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
NA
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
NA
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
NA
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
NA
</td>
<td style="text-align:left;">
NA
</td>
</tr>
<tr>
<td style="text-align:left;color: black !important;background-color: gray !important;border-left:1px solid;border-right:1px solid;">
68
</td>
<td style="text-align:left;color: black !important;background-color: gray !important;border-left:1px solid;border-right:1px solid;">
SDY146
</td>
<td style="text-align:left;color: black !important;background-color: gray !important;border-left:1px solid;border-right:1px solid;">
Age, Rheumatoid Arthritis vs Normal
</td>
<td style="text-align:left;color: black !important;background-color: gray !important;border-left:1px solid;border-right:1px solid;">
1, 26, 30, 151, 196, 207, 231, 273, 275
</td>
<td style="text-align:left;color: black !important;background-color: gray !important;border-left:1px solid;border-right:1px solid;">
NA
</td>
<td style="text-align:left;color: black !important;background-color: gray !important;border-left:1px solid;border-right:1px solid;">
NA
</td>
<td style="text-align:left;color: black !important;background-color: gray !important;border-left:1px solid;border-right:1px solid;">
NA
</td>
<td style="text-align:left;color: black !important;background-color: gray !important;border-left:1px solid;border-right:1px solid;">
NA
</td>
<td style="text-align:left;color: black !important;background-color: gray !important;border-left:1px solid;border-right:1px solid;">
Bcell: IgD, CD1c, CD24, IgM, CD3, CD10, CD38, LiveDead, CD27, CD45R/B220, CD19, CD20
</td>
<td style="text-align:left;color: black !important;background-color: gray !important;border-left:1px solid;border-right:1px solid;">
DC: 1c, HLA-DR, CD40, Dump, CD11c, CD86, CD141, CD303, CD14, CD4
</td>
<td style="text-align:left;color: black !important;background-color: gray !important;border-left:1px solid;border-right:1px solid;">
NA
</td>
<td style="text-align:left;color: black !important;background-color: gray !important;border-left:1px solid;border-right:1px solid;">
NA
</td>
<td style="text-align:left;color: black !important;background-color: gray !important;border-left:1px solid;border-right:1px solid;">
NA
</td>
<td style="text-align:left;color: black !important;background-color: gray !important;border-left:1px solid;border-right:1px solid;">
NA
</td>
<td style="text-align:left;color: black !important;background-color: gray !important;border-left:1px solid;border-right:1px solid;">
NA
</td>
<td style="text-align:left;color: black !important;background-color: gray !important;border-left:1px solid;border-right:1px solid;">
NA
</td>
<td style="text-align:left;color: black !important;background-color: gray !important;border-left:1px solid;border-right:1px solid;">
NA
</td>
<td style="text-align:left;color: black !important;background-color: gray !important;border-left:1px solid;border-right:1px solid;">
NA
</td>
<td style="text-align:left;color: black !important;background-color: gray !important;border-left:1px solid;border-right:1px solid;">
NA
</td>
<td style="text-align:left;color: black !important;background-color: gray !important;border-left:1px solid;border-right:1px solid;">
NA
</td>
<td style="text-align:left;color: black !important;background-color: gray !important;border-left:1px solid;border-right:1px solid;">
NA
</td>
<td style="text-align:left;color: black !important;background-color: gray !important;border-left:1px solid;border-right:1px solid;">
NA
</td>
<td style="text-align:left;color: black !important;background-color: gray !important;border-left:1px solid;border-right:1px solid;">
NA
</td>
<td style="text-align:left;color: black !important;background-color: gray !important;">
NA
</td>
</tr>
<tr>
<td style="text-align:left;color: black !important;background-color: gray !important;border-left:1px solid;border-right:1px solid;">
70
</td>
<td style="text-align:left;color: black !important;background-color: gray !important;border-left:1px solid;border-right:1px solid;">
SDY416
</td>
<td style="text-align:left;color: black !important;background-color: gray !important;border-left:1px solid;border-right:1px solid;">
NA
</td>
<td style="text-align:left;color: black !important;background-color: gray !important;border-left:1px solid;border-right:1px solid;">
NA
</td>
<td style="text-align:left;color: black !important;background-color: gray !important;border-left:1px solid;border-right:1px solid;">
NA
</td>
<td style="text-align:left;color: black !important;background-color: gray !important;border-left:1px solid;border-right:1px solid;">
NA
</td>
<td style="text-align:left;color: black !important;background-color: gray !important;border-left:1px solid;border-right:1px solid;">
NA
</td>
<td style="text-align:left;color: black !important;background-color: gray !important;border-left:1px solid;border-right:1px solid;">
NA
</td>
<td style="text-align:left;color: black !important;background-color: gray !important;border-left:1px solid;border-right:1px solid;">
Bcell: IgD, CD24, CD19, CD20, CD38, CD138, CD3-CD14, CD27, CD86, CD45
</td>
<td style="text-align:left;color: black !important;background-color: gray !important;border-left:1px solid;border-right:1px solid;">
DC: FSC-A, FSC-H, SSC-A, SSC-H, Lin-1, BDCA-2, CD2, CD11c, CD1c, BDCA-3, HLA-DR, CD86, CD45
</td>
<td style="text-align:left;color: black !important;background-color: gray !important;border-left:1px solid;border-right:1px solid;">
Monocyte: FSC-A, FSC-H, SSC-A, SSC-H, CX3CR1, CD14, CD2, CD40, CD11b, Slan, HLA-DR, CD16, CD86, CD45
</td>
<td style="text-align:left;color: black !important;background-color: gray !important;border-left:1px solid;border-right:1px solid;">
Tcell: FSC-A, FSC-H, SSC-A, SSC-H, Ki-67, CCR9, HLA-DR, CD19, CD56, CXCR5, CD3, CD4, CD8
</td>
<td style="text-align:left;color: black !important;background-color: gray !important;border-left:1px solid;border-right:1px solid;">
Tregs: CLA, CD127, CD62L, HLA-DR, CD56, CD25, CD3, CD16, CD4, CD45(45 subjects, Visits: Day0, Day1, Day7, Day 14 and Day28) Tregs: CXCR5, CCR6, CD45RA, CXCR3, CCR4, CD161, CD3, CD4, CD45(45 subjects, Visits: Day0, Day1, Day7, Day 14 and Day28)
</td>
<td style="text-align:left;color: black !important;background-color: gray !important;border-left:1px solid;border-right:1px solid;">
No Ab titer
</td>
<td style="text-align:left;color: black !important;background-color: gray !important;border-left:1px solid;border-right:1px solid;">
NA
</td>
<td style="text-align:left;color: black !important;background-color: gray !important;border-left:1px solid;border-right:1px solid;">
NA
</td>
<td style="text-align:left;color: black !important;background-color: gray !important;border-left:1px solid;border-right:1px solid;">
NA
</td>
<td style="text-align:left;color: black !important;background-color: gray !important;border-left:1px solid;border-right:1px solid;">
NA
</td>
<td style="text-align:left;color: black !important;background-color: gray !important;border-left:1px solid;border-right:1px solid;">
NA
</td>
<td style="text-align:left;color: black !important;background-color: gray !important;border-left:1px solid;border-right:1px solid;">
NA
</td>
<td style="text-align:left;color: black !important;background-color: gray !important;border-left:1px solid;border-right:1px solid;">
NA
</td>
<td style="text-align:left;color: black !important;background-color: gray !important;border-left:1px solid;border-right:1px solid;">
NA
</td>
<td style="text-align:left;color: black !important;background-color: gray !important;border-left:1px solid;border-right:1px solid;">
NA
</td>
<td style="text-align:left;color: black !important;background-color: gray !important;">
NA
</td>
</tr>
<tr>
<td style="text-align:left;color: black !important;background-color: gray !important;border-left:1px solid;border-right:1px solid;">
72
</td>
<td style="text-align:left;color: black !important;background-color: gray !important;border-left:1px solid;border-right:1px solid;">
SDY369
</td>
<td style="text-align:left;color: black !important;background-color: gray !important;border-left:1px solid;border-right:1px solid;">
NA
</td>
<td style="text-align:left;color: black !important;background-color: gray !important;border-left:1px solid;border-right:1px solid;">
NA
</td>
<td style="text-align:left;color: black !important;background-color: gray !important;border-left:1px solid;border-right:1px solid;">
NA
</td>
<td style="text-align:left;color: black !important;background-color: gray !important;border-left:1px solid;border-right:1px solid;">
NA
</td>
<td style="text-align:left;color: black !important;background-color: gray !important;border-left:1px solid;border-right:1px solid;">
NA
</td>
<td style="text-align:left;color: black !important;background-color: gray !important;border-left:1px solid;border-right:1px solid;">
NA
</td>
<td style="text-align:left;color: black !important;background-color: gray !important;border-left:1px solid;border-right:1px solid;">
less files
</td>
<td style="text-align:left;color: black !important;background-color: gray !important;border-left:1px solid;border-right:1px solid;">
NA
</td>
<td style="text-align:left;color: black !important;background-color: gray !important;border-left:1px solid;border-right:1px solid;">
NA
</td>
<td style="text-align:left;color: black !important;background-color: gray !important;border-left:1px solid;border-right:1px solid;">
NA
</td>
<td style="text-align:left;color: black !important;background-color: gray !important;border-left:1px solid;border-right:1px solid;">
NA
</td>
<td style="text-align:left;color: black !important;background-color: gray !important;border-left:1px solid;border-right:1px solid;">
NA
</td>
<td style="text-align:left;color: black !important;background-color: gray !important;border-left:1px solid;border-right:1px solid;">
NA
</td>
<td style="text-align:left;color: black !important;background-color: gray !important;border-left:1px solid;border-right:1px solid;">
NA
</td>
<td style="text-align:left;color: black !important;background-color: gray !important;border-left:1px solid;border-right:1px solid;">
NA
</td>
<td style="text-align:left;color: black !important;background-color: gray !important;border-left:1px solid;border-right:1px solid;">
NA
</td>
<td style="text-align:left;color: black !important;background-color: gray !important;border-left:1px solid;border-right:1px solid;">
NA
</td>
<td style="text-align:left;color: black !important;background-color: gray !important;border-left:1px solid;border-right:1px solid;">
NA
</td>
<td style="text-align:left;color: black !important;background-color: gray !important;border-left:1px solid;border-right:1px solid;">
NA
</td>
<td style="text-align:left;color: black !important;background-color: gray !important;border-left:1px solid;border-right:1px solid;">
NA
</td>
<td style="text-align:left;color: black !important;background-color: gray !important;border-left:1px solid;border-right:1px solid;">
NA
</td>
<td style="text-align:left;color: black !important;background-color: gray !important;">
NA
</td>
</tr>
<tr>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
73
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
SDY372
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
Age, Gender, Race
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
0, 7, 28, 90
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
TIV
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
Whole Blood
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
Microarray
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
HAI; NAI
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
Bcell: FSC-A, FSC-H, SSC-A, SSC-H, IgD, CD24, CD19, CD20, CD38, CD138, CD3/CD14, CD27, CD86, HLA-DR, CD45
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
DC: FSC-A, FSC-H, SSC-A, SSC-H, LIN-1, BDCA-2, CD2, CD40, CD1c, BDCA-3, HLA-DR, CD11c, CD86, CD45
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
Monocyte: FSC-A, FSC-H, SSC-A, SSC-H, CX3CR1, CD14, CD62L, CD40, CD11b, SLAN, HLA-DR, CD16, CD86, CD45
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
Tcell: FSC-A, FSC-H, SSC-A, SSC-H, CXCR5, CCR6, CD45RA, CXCR3, ICOS, CD8, CD3, CD4, HLA-DR, CD45
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
NA
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
NA
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
NA
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
NA
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
NA
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
NA
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
NA
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
NA
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
NA
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
NA
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
NA
</td>
<td style="text-align:left;">
NA
</td>
</tr>
<tr>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
74
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
SDY376
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
Age, Gender, Race
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
7 days before vaccination, 0, 1, 7, 70
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
TIV
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
Whole Blood
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
Microarray
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
HAI; NAI
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
Bcell: FSC-A, FSC-H, SSC-A, SSC-H, IgD, CD24, CD19, CD20, CD38, CD138, CD3/CD14, CD27, CD86, CD45
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
DC: FSC-A, FSC-H, SSC-A, SSC-H, LIN-1, BDCA-2, CD2, CD64, CD1c, BDCA-3, HLA-DR, CD11c, CD86, CD45
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
Monocyte: FSC-A, FSC-H, SSC-A, SSC-H, CX3CR1, CD14, CD62L, CD40, CD11b, SLAN, HLA-DR, CD16, CD86, CD45
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
Tcell: FSC-A, FSC-H, SSC-A, SSC-H, CXCR5, CCR6, CD45RA, CXCR3, ICOS, CD8, CD3, CD4, HLA-DR, CD45
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
NA
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
NA
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
NA
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
NA
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
NA
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
NA
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
NA
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
NA
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
NA
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
NA
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
NA
</td>
<td style="text-align:left;">
NA
</td>
</tr>
<tr>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
75
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
SDY645
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
Age, Gender, Race
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
0, 7, 28, 90
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
TIV
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
Whole Blood
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
Microarray
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
HAI
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
Bcell: FSC-A, FSC-H, SSC-A, SSC-H, IgD, CD24, CD19, CD20, CD38, CD138, CD3/CD14, CD27, CD86, HLA-DR, CD45
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
DC: FSC-A, FSC-H, SSC-A, SSC-H, LIN-1, BDCA-2, CD2, CD40, CD1c, BDCA-3, HLA-DR, CD11c, CD86, CD45
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
Monocyte: FSC-A, FSC-H, SSC-A, SSC-H, CX3CR1, CD14, CD62L, CD40, CD11b, SLAN, HLA-DR, CD16, CD86, CD45
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
Tcell: FSC-A, FSC-H, SSC-A, SSC-H, CXCR5, CCR6, CD45RA, CXCR3, ICOS, CD8, CD3, CD4, HLA-DR, CD45
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
NA
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
NA
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
NA
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
NA
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
NA
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
NA
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
NA
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
NA
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
NA
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
NA
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
NA
</td>
<td style="text-align:left;">
NA
</td>
</tr>
<tr>
<td style="text-align:left;color: black !important;background-color: gray !important;border-left:1px solid;border-right:1px solid;">
77
</td>
<td style="text-align:left;color: black !important;background-color: gray !important;border-left:1px solid;border-right:1px solid;">
SDY887
</td>
<td style="text-align:left;color: black !important;background-color: gray !important;border-left:1px solid;border-right:1px solid;">
NA
</td>
<td style="text-align:left;color: black !important;background-color: gray !important;border-left:1px solid;border-right:1px solid;">
NA
</td>
<td style="text-align:left;color: black !important;background-color: gray !important;border-left:1px solid;border-right:1px solid;">
NA
</td>
<td style="text-align:left;color: black !important;background-color: gray !important;border-left:1px solid;border-right:1px solid;">
NA
</td>
<td style="text-align:left;color: black !important;background-color: gray !important;border-left:1px solid;border-right:1px solid;">
NA
</td>
<td style="text-align:left;color: black !important;background-color: gray !important;border-left:1px solid;border-right:1px solid;">
NA
</td>
<td style="text-align:left;color: black !important;background-color: gray !important;border-left:1px solid;border-right:1px solid;">
less files and unclear headers
</td>
<td style="text-align:left;color: black !important;background-color: gray !important;border-left:1px solid;border-right:1px solid;">
NA
</td>
<td style="text-align:left;color: black !important;background-color: gray !important;border-left:1px solid;border-right:1px solid;">
NA
</td>
<td style="text-align:left;color: black !important;background-color: gray !important;border-left:1px solid;border-right:1px solid;">
NA
</td>
<td style="text-align:left;color: black !important;background-color: gray !important;border-left:1px solid;border-right:1px solid;">
NA
</td>
<td style="text-align:left;color: black !important;background-color: gray !important;border-left:1px solid;border-right:1px solid;">
NA
</td>
<td style="text-align:left;color: black !important;background-color: gray !important;border-left:1px solid;border-right:1px solid;">
NA
</td>
<td style="text-align:left;color: black !important;background-color: gray !important;border-left:1px solid;border-right:1px solid;">
NA
</td>
<td style="text-align:left;color: black !important;background-color: gray !important;border-left:1px solid;border-right:1px solid;">
NA
</td>
<td style="text-align:left;color: black !important;background-color: gray !important;border-left:1px solid;border-right:1px solid;">
NA
</td>
<td style="text-align:left;color: black !important;background-color: gray !important;border-left:1px solid;border-right:1px solid;">
NA
</td>
<td style="text-align:left;color: black !important;background-color: gray !important;border-left:1px solid;border-right:1px solid;">
NA
</td>
<td style="text-align:left;color: black !important;background-color: gray !important;border-left:1px solid;border-right:1px solid;">
NA
</td>
<td style="text-align:left;color: black !important;background-color: gray !important;border-left:1px solid;border-right:1px solid;">
NA
</td>
<td style="text-align:left;color: black !important;background-color: gray !important;border-left:1px solid;border-right:1px solid;">
NA
</td>
<td style="text-align:left;color: black !important;background-color: gray !important;">
NA
</td>
</tr>
<tr>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
79
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
SDY196
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
Age, Gender, Race, SLE or not
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
1, 14, 97
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
NA
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
PBMC
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
NA
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
HAI
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
NA
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
NA
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
NA
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
CD4 Tcell: FSC-H, SSC-H, CFSE, HLA-DR, CD4
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
NA
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
NA
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
NA
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
NA
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
NA
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
NA
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
NA
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
NA
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
NA
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
NA
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
NA
</td>
<td style="text-align:left;">
NA
</td>
</tr>
<tr>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
80
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
SDY197
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
Age, Gender, Race, SLE or not
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
0, 14, 35, 84
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
NA
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
PBMC
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
NA
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
HAI
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
NA
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
NA
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
NA
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
CD4 Tcell: FSC-H, SSC-H, CFSE, IgG2b-HLA-DR, CD4
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
NA
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
NA
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
NA
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
NA
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
NA
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
NA
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
NA
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
NA
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
NA
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
NA
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
NA
</td>
<td style="text-align:left;">
NA
</td>
</tr>
<tr>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
81
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
SDY198
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
Age, Gender, Race, SLE or not
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
0, 1, 14, 21, 43
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
NA
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
PBMC
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
NA
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
HAI
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
NA
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
NA
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
NA
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
CD4 Tcell: FSC-H, SSC-H, CFSE, IgG2b-HLA-DR, CD4
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
NA
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
NA
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
NA
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
NA
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
NA
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
NA
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
NA
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
NA
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
NA
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
NA
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
NA
</td>
<td style="text-align:left;">
NA
</td>
</tr>
<tr>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
82
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
SDY199
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
Age, Gender, Race, SLE or not
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
0, 1, 14, 42, 43
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
NA
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
PBMC
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
NA
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
HAI
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
NA
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
NA
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
NA
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
CD4 Tcell: FSC-H, SSC-H, CFSE, IgG2b-HLA-DR, CD4
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
NA
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
NA
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
NA
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
NA
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
NA
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
NA
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
NA
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
NA
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
NA
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
NA
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
NA
</td>
<td style="text-align:left;">
NA
</td>
</tr>
<tr>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
83
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
SDY200
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
Age, Gender, Race, SLE or not
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
0, 1, 14, 42, 43
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
NA
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
PBMC
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
NA
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
HAI
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
NA
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
NA
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
NA
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
CD4 Tcell: FSC-H, SSC-H, CFSE, IgG2b-HLA-DR, CD4
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
NA
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
NA
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
NA
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
NA
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
NA
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
NA
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
NA
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
NA
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
NA
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
NA
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
NA
</td>
<td style="text-align:left;">
NA
</td>
</tr>
<tr>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
84
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
SDY201
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
Age, Gender, Race, SLE or not
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
0, 1, 14, 35
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
NA
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
PBMC
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
NA
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
HAI
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
NA
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
NA
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
NA
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
CD4 Tcell: FSC-H, SSC-H, CFSE, IgG2b-HLA-DR, CD4
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
NA
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
NA
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
NA
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
NA
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
NA
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
NA
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
NA
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
NA
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
NA
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
NA
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
NA
</td>
<td style="text-align:left;">
NA
</td>
</tr>
</tbody>
</table>
</div>
<p><br />
The table below gives more information for each study.</p>
<div style="border: 1px solid #ddd; padding: 0px; overflow-y: scroll; height:400px; overflow-x: scroll; width:100%; ">
<table class="table table-striped table-bordered" style="width: auto !important; margin-left: auto; margin-right: auto;">
<thead>
<tr>
<th style="text-align:left;position: sticky; top:0; background-color: #FFFFFF;">
</th>
<th style="text-align:left;position: sticky; top:0; background-color: #FFFFFF;">
Study
</th>
<th style="text-align:left;position: sticky; top:0; background-color: #FFFFFF;">
Comments
</th>
<th style="text-align:left;position: sticky; top:0; background-color: #FFFFFF;">
Notes
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
1
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
SDY144
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
There are 4 panels. B-cells and Monocytes panels have FSC-H and FSC-W swapped, similarly SSC-H and SSC-W swapped
</td>
<td style="text-align:left;">
NA
</td>
</tr>
<tr>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
2
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
SDY364
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
There are 4 panels. Monocytes panels have FSC-H and FSC-W swapped, similarly SSC-H and SSC-W swapped
</td>
<td style="text-align:left;">
NA
</td>
</tr>
<tr>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
3
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
SDY368
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
NA
</td>
<td style="text-align:left;">
NA
</td>
</tr>
<tr>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
4
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
SDY387
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
There are 4 panels. B-cells panels have FSC-H and FSC-W swapped, similarly SSC-H and SSC-W swapped
</td>
<td style="text-align:left;">
NA
</td>
</tr>
<tr>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
6
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
SDY224
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
2 Panels
</td>
<td style="text-align:left;">
NA
</td>
</tr>
<tr>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
7
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
SDY396
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
8 Panels
</td>
<td style="text-align:left;">
NA
</td>
</tr>
<tr>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
8
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
SDY564
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
3 Panels
</td>
<td style="text-align:left;">
NA
</td>
</tr>
<tr>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
10
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
SDY180
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
ab titer did not have all the subjects (we cannot compare responder vs non-responder). SDY180 has around 15 panels
</td>
<td style="text-align:left;">
NA
</td>
</tr>
<tr>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
12
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
SDY80
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
Has 3 panels
</td>
<td style="text-align:left;">
NA
</td>
</tr>
<tr>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
14
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
SDY67
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
Has 5 panels
</td>
<td style="text-align:left;">
NA
</td>
</tr>
<tr>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
16
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
SDY212
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
Has 8 panels
</td>
<td style="text-align:left;">
NA
</td>
</tr>
<tr>
<td style="text-align:left;color: black !important;background-color: gray !important;border-left:1px solid;border-right:1px solid;">
18
</td>
<td style="text-align:left;color: black !important;background-color: gray !important;border-left:1px solid;border-right:1px solid;">
SDY38
</td>
<td style="text-align:left;color: black !important;background-color: gray !important;border-left:1px solid;border-right:1px solid;">
Ab titer data is not available; Only 48 files are available
</td>
<td style="text-align:left;color: black !important;background-color: gray !important;">
NA
</td>
</tr>
<tr>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
20
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
SDY241
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
This study has over 5000 files, so I will analyze them at the end. Some of the headers are inconsistent. For example: NA|NA|IgA|CD27|NA|IgM|CD45R/B220|NA|NA|NA|CD38|NA|NA|NA and NA|NA|IgA|CD27|NA|IgM|NA|NA|IgG|NA|CD38|NA|NA|NA
</td>
<td style="text-align:left;">
NA
</td>
</tr>
<tr>
<td style="text-align:left;color: black !important;background-color: gray !important;border-left:1px solid;border-right:1px solid;">
22
</td>
<td style="text-align:left;color: black !important;background-color: gray !important;border-left:1px solid;border-right:1px solid;">
SDY74
</td>
<td style="text-align:left;color: black !important;background-color: gray !important;border-left:1px solid;border-right:1px solid;">
Ab titer data is not available
</td>
<td style="text-align:left;color: black !important;background-color: gray !important;">
NA
</td>
</tr>
<tr>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
23
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
SDY296
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
NA
</td>
<td style="text-align:left;">
NA
</td>
</tr>
<tr>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
24
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
SDY301
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
NA
</td>
<td style="text-align:left;">
NA
</td>
</tr>
<tr>
<td style="text-align:left;color: black !important;background-color: gray !important;border-left:1px solid;border-right:1px solid;">
26
</td>
<td style="text-align:left;color: black !important;background-color: gray !important;border-left:1px solid;border-right:1px solid;">
SDY33
</td>
<td style="text-align:left;color: black !important;background-color: gray !important;border-left:1px solid;border-right:1px solid;">
Ab titer data is not available
</td>
<td style="text-align:left;color: black !important;background-color: gray !important;">
NA
</td>
</tr>
<tr>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
28
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
SDY314
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
NA
</td>
<td style="text-align:left;">
NA
</td>
</tr>
<tr>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
29
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
SDY312
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
NA
</td>
<td style="text-align:left;">
NA
</td>
</tr>
<tr>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
30
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
SDY311
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
NA
</td>
<td style="text-align:left;">
NA
</td>
</tr>
<tr>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
31
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
SDY112
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
NA
</td>
<td style="text-align:left;">
NA
</td>
</tr>
<tr>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
32
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
SDY315
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
NA
</td>
<td style="text-align:left;">
NA
</td>
</tr>
<tr>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
34
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
SDY514
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
NA
</td>
<td style="text-align:left;">
NA
</td>
</tr>
<tr>
<td style="text-align:left;color: black !important;background-color: gray !important;border-left:1px solid;border-right:1px solid;">
36
</td>
<td style="text-align:left;color: black !important;background-color: gray !important;border-left:1px solid;border-right:1px solid;">
SDY515
</td>
<td style="text-align:left;color: black !important;background-color: gray !important;border-left:1px solid;border-right:1px solid;">
50 files across 3 visits
</td>
<td style="text-align:left;color: black !important;background-color: gray !important;">
NA
</td>
</tr>
<tr>
<td style="text-align:left;color: black !important;background-color: gray !important;border-left:1px solid;border-right:1px solid;">
38
</td>
<td style="text-align:left;color: black !important;background-color: gray !important;border-left:1px solid;border-right:1px solid;">
SDY519
</td>
<td style="text-align:left;color: black !important;background-color: gray !important;border-left:1px solid;border-right:1px solid;">
54 files across 3 visits
</td>
<td style="text-align:left;color: black !important;background-color: gray !important;">
NA
</td>
</tr>
<tr>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
40
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
SDY113
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
NA
</td>
<td style="text-align:left;">
NA
</td>
</tr>
<tr>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
42
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
SDY305
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
NA
</td>
<td style="text-align:left;">
NA
</td>
</tr>
<tr>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
44
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
SDY202
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
NA
</td>
<td style="text-align:left;">
NA
</td>
</tr>
<tr>
<td style="text-align:left;color: black !important;background-color: gray !important;border-left:1px solid;border-right:1px solid;">
46
</td>
<td style="text-align:left;color: black !important;background-color: gray !important;border-left:1px solid;border-right:1px solid;">
SDY583
</td>
<td style="text-align:left;color: black !important;background-color: gray !important;border-left:1px solid;border-right:1px solid;">
No Ab titer
</td>
<td style="text-align:left;color: black !important;background-color: gray !important;">
NA
</td>
</tr>
<tr>
<td style="text-align:left;color: black !important;background-color: gray !important;border-left:1px solid;border-right:1px solid;">
48
</td>
<td style="text-align:left;color: black !important;background-color: gray !important;border-left:1px solid;border-right:1px solid;">
SDY585
</td>
<td style="text-align:left;color: black !important;background-color: gray !important;border-left:1px solid;border-right:1px solid;">
Study is in mice?
</td>
<td style="text-align:left;color: black !important;background-color: gray !important;">
NA
</td>
</tr>
<tr>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
50
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
SDY56
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
NA
</td>
<td style="text-align:left;">
NA
</td>
</tr>
<tr>
<td style="text-align:left;color: black !important;background-color: gray !important;border-left:1px solid;border-right:1px solid;">
52
</td>
<td style="text-align:left;color: black !important;background-color: gray !important;border-left:1px solid;border-right:1px solid;">
SDY269
</td>
<td style="text-align:left;color: black !important;background-color: gray !important;border-left:1px solid;border-right:1px solid;">
Data is available only for Day7 (we cannot do identify the longitudinal patterns)
</td>
<td style="text-align:left;color: black !important;background-color: gray !important;">
NA
</td>
</tr>
<tr>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
54
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
SDY404
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
NA
</td>
<td style="text-align:left;">
NA
</td>
</tr>
<tr>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
56
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
SDY272
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
NA
</td>
<td style="text-align:left;">
NA
</td>
</tr>
<tr>
<td style="text-align:left;color: black !important;background-color: gray !important;border-left:1px solid;border-right:1px solid;">
57
</td>
<td style="text-align:left;color: black !important;background-color: gray !important;border-left:1px solid;border-right:1px solid;">
SDY622
</td>
<td style="text-align:left;color: black !important;background-color: gray !important;border-left:1px solid;border-right:1px solid;">
Analyze them at the end (1134 files, no storage space for the analysis)
</td>
<td style="text-align:left;color: black !important;background-color: gray !important;">
NA
</td>
</tr>
<tr>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
58
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
SDY648
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
NA
</td>
<td style="text-align:left;">
NA
</td>
</tr>
<tr>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
59
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
SDY739
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
NA
</td>
<td style="text-align:left;">
NA
</td>
</tr>
<tr>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
60
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
SDY819
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
NA
</td>
<td style="text-align:left;">
NA
</td>
</tr>
<tr>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
62
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
SDY522
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
NA
</td>
<td style="text-align:left;">
NA
</td>
</tr>
<tr>
<td style="text-align:left;color: black !important;background-color: gray !important;border-left:1px solid;border-right:1px solid;">
64
</td>
<td style="text-align:left;color: black !important;background-color: gray !important;border-left:1px solid;border-right:1px solid;">
SDY34
</td>
<td style="text-align:left;color: black !important;background-color: gray !important;border-left:1px solid;border-right:1px solid;">
Ab titer data is not available
</td>
<td style="text-align:left;color: black !important;background-color: gray !important;">
NA
</td>
</tr>
<tr>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
66
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
SDY167
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
NA
</td>
<td style="text-align:left;">
NA
</td>
</tr>
<tr>
<td style="text-align:left;color: black !important;background-color: gray !important;border-left:1px solid;border-right:1px solid;">
68
</td>
<td style="text-align:left;color: black !important;background-color: gray !important;border-left:1px solid;border-right:1px solid;">
SDY146
</td>
<td style="text-align:left;color: black !important;background-color: gray !important;border-left:1px solid;border-right:1px solid;">
Ab titer data is not available
</td>
<td style="text-align:left;color: black !important;background-color: gray !important;">
NA
</td>
</tr>
<tr>
<td style="text-align:left;color: black !important;background-color: gray !important;border-left:1px solid;border-right:1px solid;">
70
</td>
<td style="text-align:left;color: black !important;background-color: gray !important;border-left:1px solid;border-right:1px solid;">
SDY416
</td>
<td style="text-align:left;color: black !important;background-color: gray !important;border-left:1px solid;border-right:1px solid;">
Ab titer data is not available
</td>
<td style="text-align:left;color: black !important;background-color: gray !important;">
NA
</td>
</tr>
<tr>
<td style="text-align:left;color: black !important;background-color: gray !important;border-left:1px solid;border-right:1px solid;">
72
</td>
<td style="text-align:left;color: black !important;background-color: gray !important;border-left:1px solid;border-right:1px solid;">
SDY369
</td>
<td style="text-align:left;color: black !important;background-color: gray !important;border-left:1px solid;border-right:1px solid;">
Less files
</td>
<td style="text-align:left;color: black !important;background-color: gray !important;">
Panel and Number of files Panel 1: 22 panel2: 13 Panel3: 13 Panel4: 8 Panel5: 14 Panel6: 8 Panel7: 22
</td>
</tr>
<tr>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
73
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
SDY372
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
NA
</td>
<td style="text-align:left;">
NA
</td>
</tr>
<tr>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
74
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
SDY376
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
NA
</td>
<td style="text-align:left;">
NA
</td>
</tr>
<tr>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
75
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
SDY645
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
NA
</td>
<td style="text-align:left;">
NA
</td>
</tr>
<tr>
<td style="text-align:left;color: black !important;background-color: gray !important;border-left:1px solid;border-right:1px solid;">
77
</td>
<td style="text-align:left;color: black !important;background-color: gray !important;border-left:1px solid;border-right:1px solid;">
SDY887
</td>
<td style="text-align:left;color: black !important;background-color: gray !important;border-left:1px solid;border-right:1px solid;">
Less files
</td>
<td style="text-align:left;color: black !important;background-color: gray !important;">
Panel and Number of files Panel 1: 29 Panel2: 29 Panel3: 29 Panel4: 29 Panel5: 29 Panel6: 29
</td>
</tr>
<tr>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
79
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
SDY196
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
NA
</td>
<td style="text-align:left;">
NA
</td>
</tr>
<tr>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
80
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
SDY197
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
NA
</td>
<td style="text-align:left;">
NA
</td>
</tr>
<tr>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
81
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
SDY198
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
NA
</td>
<td style="text-align:left;">
NA
</td>
</tr>
<tr>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
82
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
SDY199
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
NA
</td>
<td style="text-align:left;">
NA
</td>
</tr>
<tr>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
83
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
SDY200
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
NA
</td>
<td style="text-align:left;">
NA
</td>
</tr>
<tr>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
84
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
SDY201
</td>
<td style="text-align:left;border-left:1px solid;border-right:1px solid;">
NA
</td>
<td style="text-align:left;">
NA
</td>
</tr>
</tbody>
</table>
</div>
</div>
<div id="sql-querying-for-metadata" class="section level4">
<h4>SQL Querying for MetaData</h4>
<p>The ImmPort schema has 115 tables with subject information. For final subjects’ meta data, file_info, expsample_2_file_info, expsample_2_biosample, biosample, arm_2_subject and subject tables were queried. The meta data was later separated based on the panel markers idenfied in the previous step. A separate SQL query was used for each study, because they had different filtering identifiers.</p>
</div>
</div>
<div id="gating-hierarchy" class="section level2">
<h2>Gating Hierarchy</h2>
<p>There were no material for previous gating hierarchy used in the original studies. We used a common gating hierachy across the studies (with similar marker panels) based on prior knowledge gathered from studying other Influenza papers from ImmPort database. DAFi auto-gating was used for the gating analysis. The gating co-ordinates used and the gating strategy can be found in the individual reports.</p>
</div>
<div id="acknowledgements" class="section level2">
<h2>Acknowledgements</h2>
<ul>
<li>National Institute of Allergy and Infectious Diseases UH2AI132342</li>
<li>NCATS U01TR001801 (FlowGate)</li>
</ul>
</div>




</div>

<script>

// add bootstrap table styles to pandoc tables
function bootstrapStylePandocTables() {
  $('tr.header').parent('thead').parent('table').addClass('table table-condensed');
}
$(document).ready(function () {
  bootstrapStylePandocTables();
});


</script>

<!-- tabsets -->

<script>
$(document).ready(function () {
  window.buildTabsets("TOC");
});

$(document).ready(function () {
  $('.tabset-dropdown > .nav-tabs > li').click(function () {
    $(this).parent().toggleClass('nav-tabs-open')
  });
});
</script>

<!-- code folding -->


<!-- dynamically load mathjax for compatibility with self-contained -->
<script>
  (function () {
    var script = document.createElement("script");
    script.type = "text/javascript";
    script.src  = "https://mathjax.rstudio.com/latest/MathJax.js?config=TeX-AMS-MML_HTMLorMML";
    document.getElementsByTagName("head")[0].appendChild(script);
  })();
</script>

</body>
</html>
